var title_f24_14_24800="Factitial dermatitis 3";
var content_f24_14_24800=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F67422&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F67422&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Factitial ulcerations",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Self inflicted ulcerations. The lesions have a geometric shape and are at the same stage of development.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24800=[""].join("\n");
var outline_f24_14_24800=null;
var title_f24_14_24801="Patient information: Subdural hematoma (The Basics)";
var content_f24_14_24801=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/17230\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/1/27667\">",
"         Subdural hematoma",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?8/47/8947\">",
"         Patient information: Closed head injury (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Subdural hematoma (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/subdural-hematoma-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H28150272\">",
"      <span class=\"h1\">",
"       What is a subdural hematoma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A subdural hematoma is bleeding on the surface of the brain. The bleeding occurs under the tough, outer covering of the brain, called the &ldquo;dura&rdquo; (",
"      <a class=\"graphic graphic_figure graphicRef65181 \" href=\"UTD.htm?27/1/27667\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      An injury to the head causes most subdural hematomas. The most common causes of these injuries include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        A car crash",
"       </li>",
"       <li>",
"        A fall",
"       </li>",
"       <li>",
"        A physical attack",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      There are 2 main types of subdural hematomas:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Acute &ndash; This type happens in the first hours after a head injury. If the bleeding continues, the subdural hematoma can keep growing, days after the injury.",
"       </li>",
"       <li>",
"        Chronic &ndash; This type happens most often in older people whose brains have shrunk slightly due to age. In these people, a mild head injury causes bleeding on the brain&rsquo;s surface. The injury can be so mild that the person doesn&rsquo;t even notice it. The hematoma grows slowly, over several days or weeks.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28150287\">",
"      <span class=\"h1\">",
"       What are the symptoms of subdural hematoma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some people pass out after getting a serious head injury and a large, acute subdural hematoma. Other times, the symptoms appear later and can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Headache",
"       </li>",
"       <li>",
"        Vomiting",
"       </li>",
"       <li>",
"        Weakness",
"       </li>",
"       <li>",
"        Numbness",
"       </li>",
"       <li>",
"        Trouble walking",
"       </li>",
"       <li>",
"        Slurred speech or being unable to speak",
"       </li>",
"       <li>",
"        Acting less alert than normal",
"       </li>",
"       <li>",
"        Dizziness",
"       </li>",
"       <li>",
"        Confusion or trouble thinking",
"       </li>",
"       <li>",
"        Sleepiness",
"       </li>",
"       <li>",
"        Seizures",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28150302\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Tests include imaging tests that take pictures of your brain, such as an MRI or CT scan. These will show the subdural hematoma and how big it is.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28150317\">",
"      <span class=\"h1\">",
"       How is subdural hematoma treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The treatment depends on the size of the hematoma and your symptoms. You might need surgery to drain the hematoma and relieve the pressure on your brain.",
"     </p>",
"     <p>",
"      If you are taking medicines known as &ldquo;blood-thinners,&rdquo; such as",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?6/12/6342?source=see_link\">",
"       aspirin",
"      </a>",
"      or",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?33/2/33830?source=see_link\">",
"       warfarin",
"      </a>",
"      (sample brand names: Coumadin&reg;, Jantoven&reg;), your doctor might tell you to stop taking these medicines. Be sure to talk to the doctor who first prescribed these medicines about when and if you should take them again.&nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28150332\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/47/8947?source=see_link\">",
"       Patient information: Closed head injury (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?24/14/24801?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 17230 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-0B08567BAA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24801=[""].join("\n");
var outline_f24_14_24801=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28150272\">",
"      What is a subdural hematoma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28150287\">",
"      What are the symptoms of subdural hematoma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28150302\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28150317\">",
"      How is subdural hematoma treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28150332\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/17230\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/1/27667\">",
"      Subdural hematoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/47/8947?source=related_link\">",
"      Patient information: Closed head injury (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_14_24802="Chlamydia";
var content_f24_14_24802=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Chlamydia (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?24/14/24802/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/14/24802/contributors\" id=\"au1704\">",
"       Jeanne Marrazzo, MD, MPH",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?24/14/24802/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/14/24802/contributors\" id=\"se614\">",
"       Noreen A Hynes, MD, MPH, DTM&amp;H",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?24/14/24802/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/14/24802/contributors\" id=\"de8449\">",
"       Allyson Bloom, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?24/14/24802?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      INTRODUCTION",
"     </span>",
"    </p>",
"    <p>",
"     Chlamydia (pronounced klah-MID-dee-uh) is the most common sexually transmitted infection in the United States [",
"     <a class=\"abstract\" href=\"UTD.htm?24/14/24802/abstract/1\">",
"      1",
"     </a>",
"     ]. There are about four million cases of chlamydia in the United States every year.",
"    </p>",
"    <p>",
"     Chlamydia and gonorrhea (another sexually transmitted infection) cause similar signs and symptoms, including discharge from the penis or vagina and pain with urination. However, chlamydia sometimes causes no symptoms. In addition, chlamydia can cause serious long-term complications in women who are not treated. Fortunately, chlamydia is curable with antibiotic treatment. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/44/1730?source=see_link\">",
"      \"Patient information: Gonorrhea (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     More detailed information about chlamydia is available separately. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=see_link\">",
"      \"Genital Chlamydia trachomatis infections in men\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/46/42728?source=see_link\">",
"      \"Genital Chlamydia trachomatis infections in women\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      CHLAMYDIA CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     Chlamydia infections are caused by a bacterium, Chlamydia trachomatis. The infection is usually spread during sex. A man does not have to ejaculate to spread the infection. It is not possible to become infected with chlamydia by touching an object like a toilet seat.",
"    </p>",
"    <p>",
"     Your risk of getting chlamydia is greater if you have a new sexual partner, more than one sexual partner, or if you have had chlamydia before.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      CHLAMYDIA SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Chlamydia infections can cause mild to severe symptoms. However, some people have no symptoms at all. This means that it is easy to spread the infection without ever knowing you are infected.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Women",
"     </span>",
"     &nbsp;&mdash;&nbsp;Up to 90 percent of women with chlamydia have no symptoms at all. Of those who do, the most common symptoms include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Vaginal discharge",
"      </li>",
"      <li>",
"       Abnormal vaginal bleeding",
"      </li>",
"      <li>",
"       Abdominal pain",
"      </li>",
"      <li>",
"       Pain during sex",
"      </li>",
"      <li>",
"       Burning or pain with urination",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Men",
"     </span>",
"     &nbsp;&mdash;&nbsp;Up to 70 percent of men with chlamydia have no symptoms at all. The most common symptoms of chlamydia in men include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Burning or pain with urination",
"      </li>",
"      <li>",
"       Discharge from the penis",
"      </li>",
"      <li>",
"       Pain or tenderness of the testicles",
"      </li>",
"      <li>",
"       Swelling in the scrotum (",
"       <a class=\"graphic graphic_figure graphicRef68075 \" href=\"UTD.htm?21/43/22194\">",
"        figure 1",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Men who have sex with men can develop a chlamydia infection in the rectum or anus.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Related disorders",
"     </span>",
"     &nbsp;&mdash;&nbsp;Uncommonly, people with chlamydia develop a form of arthritis, called reactive arthritis. It can cause a cluster of seemingly unrelated features, including joint pain (arthritis) and uveitis (an inflammation of the eye). (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/0/30721?source=see_link\">",
"      \"Patient information: Reactive arthritis (formerly Reiter syndrome) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      CHLAMYDIA DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     Testing for chlamydia is done in a doctor or nurse's office with a sample or urine or with a swab of fluid from the vagina or from the cervix (in women) or urethra (in men). Results are usually available within 24 hours.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H14829205\">",
"     <span class=\"h1\">",
"      CHLAMYDIA SCREENING",
"     </span>",
"    </p>",
"    <p>",
"     Once-yearly testing for chlamydia is recommended for all sexually active women who are younger than 25 years old, even in the absence of symptoms. This is because chlamydia is common in this age group and infection usually does not cause symptoms.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      TESTING FOR OTHER SEXUALLY TRANSMITTED INFECTIONS",
"     </span>",
"    </p>",
"    <p>",
"     If you or your sexual partner are diagnosed with a sexually transmitted infection like chlamydia, you should have testing for other infections, including HIV, gonorrhea, hepatitis B, trichomoniasis, and syphilis. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/60/1986?source=see_link\">",
"      \"Patient information: Testing for HIV (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/44/1730?source=see_link\">",
"      \"Patient information: Gonorrhea (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/45/31447?source=see_link\">",
"      \"Patient information: Hepatitis B (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      CHLAMYDIA COMPLICATIONS",
"     </span>",
"    </p>",
"    <p>",
"     Chlamydia in women can lead to a serious infection called pelvic inflammatory disease (PID). If chlamydia is not treated, up to 30 percent of women may develop PID. PID can cause scarring of the fallopian tubes, which can lead to infertility and an increased risk of ectopic pregnancy (a pregnancy that develops in the fallopian tube rather than the uterus). (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/43/38578?source=see_link\">",
"      \"Patient information: Ectopic (tubal) pregnancy (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      CHLAMYDIA TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     Treatment of chlamydia is the same for women and men. For most infections, experts recommend a one-time antibiotic treatment that is taken by mouth, azithromycin. Azithromycin is safe to take during pregnancy.",
"    </p>",
"    <p>",
"     Anyone who is allergic to azithromycin (or erythromycin) can take another antibiotic, doxycycline, but this must be taken twice daily for 7 days. Doxycycline is not used in pregnant women because of the risk of harm to developing teeth and bones in the fetus.",
"    </p>",
"    <p>",
"     Some people who are infected with chlamydia may also be infected with gonorrhea. Thus, testing for gonorrhea is done at the same time as chlamydia testing. If the patient has both infections, additional treatment will be needed. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/44/1730?source=see_link\">",
"      \"Patient information: Gonorrhea (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Sexual partner treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;Treatment is important for you and anyone you have had sex with recently, whether or not he or she has symptoms or has a negative test for chlamydia. Your doctor or nurse might ask you to tell your sexual partner(s) to be treated. In some cases, your doctor or nurse will give you a prescription for both you and your partner.",
"    </p>",
"    <p>",
"     You should not have sex until both you and your partner have been treated. It is possible to be infected with chlamydia more than once.",
"    </p>",
"    <p>",
"     If you take the recommended treatment, you will not need to be tested in the short term to make sure that the chlamydia is gone unless you continue to have symptoms. If symptoms do recur or occur for the first time after you are treated you should see your doctor or nurse again.",
"    </p>",
"    <p>",
"     It is recommended that anyone with chlamydia have another test for chlamydia three to six months after their diagnosis, because many people (as many as 25 percent in some studies) are re-infected from untreated sexual partners.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      CHLAMYDIA PREVENTION",
"     </span>",
"    </p>",
"    <p>",
"     The most effective way to prevent chlamydia is to avoid sexual intercourse. Because this is not practical for most people, the following tips are recommended:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Men should use a latex condom every time they have sex.",
"      </li>",
"      <li>",
"       Discuss testing for sexually transmitted infections with your doctor or nurse. If you are in a long-term relationship and neither of you has sex with anyone else, you have a lower risk of sexually transmitted infections.",
"      </li>",
"      <li>",
"       See your doctor or nurse if you have any symptoms of chlamydia or another infection.",
"      </li>",
"      <li>",
"       Do not have sex if you or your sexual partner has abnormal discharge, burning with urination, or a genital rash or sore.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2287406613\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5509953\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/39/33395?source=see_link\">",
"      Patient information: Avoiding infections in pregnancy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/52/23362?source=see_link\">",
"      Patient information: Chlamydia and gonorrhea (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/20/35138?source=see_link\">",
"      Patient information: Ectopic pregnancy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/13/16594?source=see_link\">",
"      Patient information: Genital warts (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?26/14/26850?source=see_link\">",
"      Patient information: Pelvic inflammatory disease (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/0/29698?source=see_link\">",
"      Patient information: Reactive arthritis (Reiter syndrome) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/57/1940?source=see_link\">",
"      Patient information: Screening for sexually transmitted diseases (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/61/10195?source=see_link\">",
"      Patient information: Syphilis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/50/33570?source=see_link\">",
"      Patient information: Vaginal discharge in adults (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/30/18914?source=see_link\">",
"      Patient information: Epididymitis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/44/4803?source=see_link\">",
"      Patient information: Urethritis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/34/3618?source=see_link\">",
"      Patient information: Newborn conjunctivitis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/2/12322?source=see_link\">",
"      Patient information: Bartholin&rsquo;s gland cyst (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5510054\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/44/1730?source=see_link\">",
"      Patient information: Gonorrhea (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/0/30721?source=see_link\">",
"      Patient information: Reactive arthritis (formerly Reiter syndrome) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/60/1986?source=see_link\">",
"      Patient information: Testing for HIV (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/45/31447?source=see_link\">",
"      Patient information: Hepatitis B (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/43/38578?source=see_link\">",
"      Patient information: Ectopic (tubal) pregnancy (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/4/64?source=see_link\">",
"      Acute cervicitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/58/934?source=see_link\">",
"      Long-term complications of pelvic inflammatory disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=see_link\">",
"      Genital Chlamydia trachomatis infections in men",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/46/42728?source=see_link\">",
"      Genital Chlamydia trachomatis infections in women",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/36/21063?source=see_link\">",
"      Lymphogranuloma venereum",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/45/11992?source=see_link\">",
"      Pathogenesis of and risk factors for pelvic inflammatory disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7270?source=see_link\">",
"      Pneumonia caused by Chlamydophila (Chlamydia) pneumoniae in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8408?source=see_link\">",
"      Screening for Chlamydia trachomatis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35832?source=see_link\">",
"      Treatment of pelvic inflammatory disease",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Centers for Disease Control and Prevention",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/std/Chlamydia/STDFact-Chlamydia.htm\">",
"      www.cdc.gov/std/Chlamydia/STDFact-Chlamydia.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       The American Social Health Association",
"       <br/>",
"       (www.ashastd.org)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?24/14/24802/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 18, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?24/14/24802?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24802/abstract/1\">",
"      Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24802/abstract/2\">",
"      Greer L, Wendel GD Jr. Rapid diagnostic methods in sexually transmitted infections. Infect Dis Clin North Am 2008; 22:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24802/abstract/3\">",
"      Khan A, Fortenberry JD, Juliar BE, et al. The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment. Sex Transm Dis 2005; 32:260.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f24_14_24802=[""].join("\n");
var outline_f24_14_24802=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           INTRODUCTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           CHLAMYDIA CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           CHLAMYDIA SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           CHLAMYDIA DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H14829205\">",
"           CHLAMYDIA SCREENING",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           TESTING FOR OTHER SEXUALLY TRANSMITTED INFECTIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           CHLAMYDIA COMPLICATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           CHLAMYDIA TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           CHLAMYDIA PREVENTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/43/22194\" title=\"figure 1\">",
"           Male anatomy PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f24_14_24803="Chest x-ray nondisplaced posterior rib fractures";
var content_f24_14_24803=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F83500&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F83500&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 602px\">",
"   <div class=\"ttl\">",
"    Chest x-ray nondisplaced posterior rib fractures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 582px; height: 387px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The chest x-ray is from an 80-year-old female who complained of chest pain following trauma. Nondisplaced posterior fractures of right sided ribs 6, 7, and 8 are noted (magnified and red arrows, B). There is no evidence of pneumothorax.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24803=[""].join("\n");
var outline_f24_14_24803=null;
var title_f24_14_24804="Phenylephrine and zinc sulfate: Patient drug information";
var content_f24_14_24804=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Phenylephrine and zinc sulfate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/10/4258?source=see_link\">",
"     see \"Phenylephrine and zinc sulfate: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F209438\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Zincfrin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691838",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat eye irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702737",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to phenylephrine, zinc sulfate, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016071\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696923",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use for more than 3 days. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016072\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blurred eyesight. Use care when driving or doing other tasks that call for clear eyesight.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016074\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016069\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 15 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696549",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is used on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016076\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12043 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.25.216.6-2972EEEA2C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24804=[""].join("\n");
var outline_f24_14_24804=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209438\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016067\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016066\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016071\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016072\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016074\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016069\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016070\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016075\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016076\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/10/4258?source=related_link\">",
"      Phenylephrine and zinc sulfate: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_14_24805="Morphea and lichen sclerosus";
var content_f24_14_24805=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82529%7EDERM%2F53986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82529%7EDERM%2F53986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Morphea and lichen sclerosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 260px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD0tip4I6GkTBYFiM9qJhnG0c45pgf5vk6DrXj+p9G0NmYdjwO9NzuUfShunPQ0gcFecc+npSaBLQeSVxjpTtuFUj/9VRA468gU7PHXgGpt1BjHOME59KgkdQD654p0h3nC8DtTQuQO5ByKZWwyMkKV5+b9KjDncR39anTABJPzAH61CQMlsckcik5W1QWTHyPuiCkj3NIynaOwHQVUBYklumetXI9zlS2AvAFPmuUlyoIpNykHgA/pU1vg5Y/dHQUtwiEjAC5GKbFGVUsD0p3syXZomEg24H41GSOueOlNY7F68E9KfcIEjTHrim7iTGBsHC8AUrsQAepHWo5DwT696YW+UDnOaNx2JN3B5walgYbyHJxjgVXbsO/rTrVgJBwTmmhMklYM7bV9hVTP5dKvhV2ksACO1UJHyTnvVtXEgZvkOOlQOccEnH9afkZOelRu24E54zUJjQmMEE9uKhlYEkA0ruAcdc8VDuHOenXNUnoLUibKqw54p6YAGR83ahACSzZIPGKe4BXgfhUPXQrluQyk7vX69zTHfGCOo708DOCevamqvr1JzU6BYTYflyevJqGVCQSMHHNWgDleMVGyjbnv2NFtQXkZzJwQvf3pgUg5PHsafMGEhCnpzQ2QCRnnrWkrcpSbI48lwxzmp3G4Yz361CDkccAdaN3IFRbQbQ0jDZ6tUSqS5LE4p8r5ODnP9aYxPIJzxStqAuckEDkH8qr37bYwTnbipkG1sHgA5qtfMC2ByQK0i1uZNe8ZyjdKxPTPGa04oy0WcgZ/lWQ0xR0A6k1rQTbrUZAyP5Un3Zs2xdhYjkjHrTJsHYO5z1706R8KjAcdPrTGXcFPYHil5Iz82Nl54wSOlOQkRsASKj38kYyRTJ5Ci9Du6Y/wp6bg10AYGNxGehobBGSD1/KqQlLSKSMAcZq2jZX0pLfUzae4xshwc/dHH+FQzYZ97c4PAqZ92WwM1AY28nB6nt6VVk0Su5XlfLHJwvtUEBIjPGMNxVhkGSOn1plsB5O2QEEHg4prQGtCCVSWxjPGDUEiZyWOc8irEnBI5GP51FLu3Z4HOcVfU532PoVwpXIqKNMSHsB0pG4YhTgGlZvTgiuax2A5B49RVTkFu3FTtjHTBNQSHOSRge9U9WNaCq3Jx0xTHclR6d6FG1GJHOKVsbcdc01sMIMlvanbgr49aYGKDkHnrSSMfNJHUj9alvuD3FUKbjGcY6E1FK3LFeuf0oZcsCTgEZIPaiZD8pAyrAisegWuRSOGCjgilWQlQCcDv9agmU7lHTpTtrJIoxnPJqlLqNaFqR8xHByafbuQwxz2P1pjKN4APy1IqhHOe9CWonsSuBIhHAP9ajnJCgEHcKWVwCdueopkkwYgjk/1q7shKzGj5lIOelIflAwetOAAUNnJzSxruA9aaLuiFxkHsO1LGeVHNN6khjwBT1wGGeB7U07j6EsrEdCKz3PJ7jrV6chQcdhWbIQ27bxgVaFFaEgYFW77ajkGYxt45qOLO3r17VIGGRkkAdKkGrEB4k9hTJU3E4NPkOHJznPAFNyV5Yd8DFOOodhsfB9Qe1KzHa5z0P51DI/OGyM88fpS7vn69fWlIuwofMnTGenpSbiW49eM0u5ckDv19qSdlGCvGOmKl7E9RTnevXHSmsMhwB16U0PkcnniovMO85Iz2o30C1iKQbTnHzVDM+EBxz6UyacNKRk4JpGcyIcjPH51S2L5dbiJICh5570zkSBgeBUMasmdx5PP4USPt6n2peQ7diQuBJ8x4Hf1qNn+Yc5HpULyYyM9KiRypxnpSSvsCRZlkAXHrxVG4lOSeoHBqSUkgbj1HFVp8bQADu9apOwJXKzSqUCnG4GtK0b5Ardz+lZBO+UYADCtC1IDDIO7qaqQSjZFqQEPhunPSmrIQoBwDzSbi4YjqDUQyQFPfvWaepD1HxkByf51G7l365FJghiOoxUkK7kbPBpqV9CHsU4YmdsdBn8KvooViDzgflTljyu4YBAoZwpJ9e/tUpakXuBAKqQe/WoZFBLKMgYyPenxMMMe3JqGV9oQY57/AErVK5mkyCdf0P5mooMM5JzTZZMKQ3GTwaW134AHXJ/KmBFIVcjAwScc1VuOGBwc4q3IjRkFlyGPY9KqXjbGKnnt+FXqtDNWbPfS3BB7UjsMDtUfK5xgk0x87QO/XNYPyOpEit271G+cYxnB6UDufQd6jy2M9CTQMfj246UwqQQecZ5zUm8KSuMnHWnFNxVWbA+nUUnpoUmR3RwMoeP5VHBkDc/PPcdacAHQpgAgnB9RTokBZV9uayk2n5iexI0e4hgd2RgE+npUD7QoxkL6VaicqnlnBXioJlBkfCkYOMelVZpArkRTcBznFPVM8n8DTfuKSOnQULNhh9KSshFpbcbQRyvY1UnciUAc54qyJv3ZDcY6fSs2aXa2706UNqI0rsmZznHX1HpUay8lj0quXZnJA6GpSAyZx9aQ2rbkgLABt2Bjv61PA4ZV7MPvGqDPjCHOBTY5CpYnIBFCfLqLluXWOZWxSM3Xb0FVoJwXYdSfX0pjufNK5OK0i0OxZLs3yH9O9V7nj8xTZJCXB54ovTmLrlsgkVrYa7ERb5uvTim+bwfUVGgA+Y9DSs6qQSB6VOi3C1wdj5g460h+6xZsCoZH3NjGRTygKYY85xTj5DtYiYZbOcnrmnx927A96cIlwuDxzTGXardgamSV7lbqwwOFbJ6E8/4UTyKU9AOarytuI29OlRyNyCOmefpSXYOUlkkITI4OM0wsWGTncBmkJ3qM9+T703JAx+GardWFYruoKkZw3UU45UKM9RmmyHaD69jVfczMMHipWpe4SNl06evXt6VHPmQryOtP8vAJJ5HamnsTzx+lUn3HYbtAc8d81HIMk44yetSD584B4pm3PB6rU83QVxrNyoxkiq8p6HA5BJqxIPn46jNVpxgDPUnGKSe6Yo2KJYCcYGM1dh6lj0qkVH2gc+2a1oEABAxkgU532CpKxJACY2JAAJ60xlIXIOQPWrKIohwcE5/KorhtsbY6Y60rWRjzXehWjIIYN6UsJJZhyeOabCjFuc4PH0qYRlCMnHbPrTs1sDtdocX+XC8AUx1O0bj838/WpZUIhdeM9RTAjMgHGO59KqOjSZm3poRrlMtkYyaglPfkjrVmVSEQtg5bmoiPvAgYIIFOXkTfUpJGZE+XjjgY61N5LRydT0x9M1NajapHBI/QUydt6SEHnjnvWkbMUk9yG6tJ44Y34KnOfUVkX/8AAQOcd66Cd3uLYrGD52OvbANY+oKDsXjjNaN3RhF+8e3eb8/XtSeZkYzz61Aq7SQeTUqp3GBxXGjsdkSN8pIJ4wKQHop61E2XIHTFO68E5NOTuNDzywxz65p0jFyAf+AY9agD/Oeflp7S/KGXqvU1Ld7tlEiYMZGeSeQamhQsy7TnHT1qKBwY8sBuGcH1FTQFUZWAOOvNK2tyW+hLEm/Ixz0pGVCjKBg9z61NG8YZw31HtVackrweelUyb6lRlbHXg8VQu5DGQScAd6vzSMExtyB0NY+oM5X1IPpWMrJFxV3qON8QpDH8KRZPNU+vaqUERcr5nUHkVpxxxryoIpLVXuatWGW+cYHbmp1K4IFRcxk47+lIufmFNaES1EkI+bnnIxQzrs547VE+CWJ7dqicOzDYpOapJWKsE8jBjs7jrTUmJA3Z+Xr9amjtnjwJBznrSSxgDI5JPNVyO1xXXQaX3KpXJxzTbpzsXOc9CaQyhepUZHSpWcOqg4KjkitIySQ1oQ5Pk4A68/SoGDMxI6CrGSVwowCeKYZFxxgbfah6i2ZEuS/HPH51K2RHnBJqDdyccGkuZ3VcDPzfpVRLSuWtx2DIOepFMA8xiSCR2H9agtZ90LlmJI9fWpoH82IHB3VEmrjaaRFcxBSvl9ACKixEEJcYJFTz7gQMjGKidSclgNtNSTMyqMRxjn5e/wBKZLnbnJwafLGSzL780yQYUqTkcGlFFJjHI2jnkcmowAJBnuc/SnLjCAcknJzUbt86rsP+FKTsVsDN+9Ud2PWknUJwO/WnyIVXeeNvTNRNGzklsmo5ncm/UY3MmVGA3alWLLHnrUqQsMOenYUI+H2kcj+dN3T12Jb7Eezg4HOcVUulAxk9O1aixHeeuSelU72DEeSMY5/GhN7ijLUxgQ0q4BznjitOLgjPHvVGBWMmAozmtXy1JwCSKqSvK5dVpWHoG8rKjA7VNHb+cgyOO4pscpICcADkA1etOOcA/KTiqdtDnYz7EFG4DGRgVSePEnHQHjNa0pLR9eg4+tU1XLFW5wM0iLszp3bnggZI/wDr1D53krtc9cYNaNxAGU4Ge/Ws69gJk2rjAIOad0yotPQbLP8AL82Dz0qJ2bapxwDimXSBMMckDtU6ASQEDnIz+VVd3sJ2I48CUgNg5/OnfJDMJP4/7p6GhYwDkfeKg1C4CzR7gX28la0WgpMtTzMbQunXYQP9msiUb4gMZKA859K2GkiVZiD90HaO5qlJtktn24U9TxWr97Q59VqeotMwY9M+tL5pIGTjAqrLIByOneovOyo6+tcCn1R32NFWIKv3AzStJ1cHrVKG4Una3Uins642joad+pNtSckhC2e/SrMCgovP1AqrC4DKp6AVoIU3Axjn0qY6jemgkSBVZevJ4qZGbbg5GOM0nmqvOzbk4x6UPdNgBQFA7irsRqTRI4xt5XrzSsnduDjNQLJIf4jg9TUqkBMEkn1oa1BkcoDoNxxisy4gXepBznitOZgBtxk9qpPtMgBPepa7lxdiuLQA5BpyQEqSD3xVl2Crjb74pokySB2HSoUV1C7epCts2R6A0/yAOR1NTNIWXgYIFRwyZkK9/WtEuhLbsEdnHuLMeB1FPHlRYKjPamSOykkN1JFVipIxuNUl2Hr1Jri4LHgAYGcnrVGZN/Izg8mrHlkrggkmoHjkSLGfb60PWyHa2xSiiB3MwBB/ShBGJWQk8dh3qS2idhIMYXr9agkt2IbG7I6kmsrWXMi+thZR5LORIAG7VVaYMQqjOByaHgJkR2JIxj61HcZjDbFyTjmqTfQaRLEcSduTzUlwUdQWcZIyPaoYwyDac5POKjA2EMCSR2IreMerGnqNgj8rcu76VZtpSGKlu/WoJZQVBJHHFPYIkK8/M3J55qHbmLk7oteYspOOq1C822Jxxk81H5irEGUHmq5k3KxNQY8upEzEyBmOc96HcB8evempgDJzkZpfmfA2445P40baDW4bfmDk/T3qaOMsRnGR196S3QtIofkBs1otGNjbgBzx9KFqE5WKkkXynIypqNoDtyvAqzPzGoB6H86bkiIjHU0JpydyNbCJGoiG4Hg8UxIF8wHHOakjYELgHgc1CZQHOcHPBqlqtSbMlXDSE9Np61SvgvkyHHOKsNGTC2zjbVO5LPFwMdsUm0thqOpj2+VkdSQfm6g1sxqCoHQnr+VZkSAHav3gSau7mzHwVZutJvqjSqrj8A4BHPrUkEwjIU8gdvWowxzk9ADUEj4kxjPUCiUr6maV9DaikXbkHIwcc9agkb720cHvVRZ9sBY8YPakN4rrjI4GT700Q4dS00gUkYG3GBVa46ZPAxUcN0C4DHqadf3MYRlGM7cU4u+hm42MqeUPKqH7vP41Zs2w4AweCBVAnc2cgEDAqa1OSvPUcj3pq/UtotlAVXJGSdvFQI2x2ymSwK59qsfMzAnOFH51WZzBMh6jvmto6kWvoWXhE0sJEeNsJV8dWPUVVjdUhbIKkn5h3Aqy94ftp2giAADb3wR1+tVCweSUrgqg/iHJFXojJq530ijP3u3SqUsgi3HnHUk0SSMQNp5IqlcsypmQ8ntXnLsd1tSzHdqScKfY+tXYZwSAeK5bzHZmZHYEH9K0La+BCeYd3PXvWvKJ6HTQFSCDn2q7GSOBnIHWsGGeQkBeTWtC7qPmPJ6ihLWwLUvRpK2ChyV5we9OUzFS+Bj6VDbJLvBibgc1YWKcgZXAHXNapaBfWwRk5AJ9jVnGBkEHPSojbgyM0j8n+FatoqCPgbeOAaXKJ9yn5LSlm6DPFRm3Bz/CB3NaCgDnIzn9agypbG78aHFBcpSxH5QQd3f6VEqbXOTljxV+YeZjYOfSqqRM04HvxWbjYE+gqoQhz+AqJECurYIzyR61d2EMVZtpXpgU9ERdxeJpAB0BxVpC5imYJDKeACeee1QhpBLsC5IPpV5VUEGRwue/X8KgZlzlA27vQ0Cd2O2SMp+XaOmaSe3AUA9u9XhkovHfvSXds5w5YFByQKdrakp3M+NUWI56HBrLykkzndwT6VvSxosJyQAehrIhTYzocYPOfek7vRFw6ldolfdgEgdMCs54ih/eKclga2fNMbhWHJP5iq90UmnK84Xniko63RSbuZoOGZ279KjJw2cDIbOavrbp5gOTiqkgUSybl446VtctIgZEkYggDccYpsyBEUnliMYqzCi+cXdT93A+tNmiKyKx6Abiaxkyk9bFQtlG+XhR6dDSeWFWPBwxPIqZF3qfnIDnJHTFIRwwBBI4H0pNa6CdypM4j3MEyoOMU5WOM9qdMp8sooBwRn39KYQyxAZ4zwaaRNtS3CBhSTkqf1q3Kf3eBwxGapQEFfYDFXQpd43GABxg96SbRL3uyrOSgwec0Z3YA6AZxS3beW+7HzZxzUcTbCpPc4FQ3roVa6uOCsFwmN2f0qnLG7ysp4xzWmVI5PXrVSUfOeeWHP4VSWhK3EikIQhh1yCKSRd1ueB14p4xlSFPXJ96e2EXYRz0qo9xMwTH5ZJzyTwK0IV83aw+6DimGFXYyc4zjFTSusSLsGCecUobO45yvoLdwFU9DjB9KpSBcqQfm4qWaZ2Rlf681T38853Z7+lNa6ExTS1JZD5kByPas1l2NgdMY+tWzIApB/i6GqQy5bf1U4FVbsUhofbkHqT19KbNM+CGzk9+9PkVsL65GKZMQQQBnPSk0DSIVYq4weMfhU1tuWVBuG01BkKoB7cU+LO0KeCp4NO3UzltoaoZyo2tzmo5yHOMgKF4z3qFHIBHqOamKh4ScEH1qk9TNKw144jHIXkKvtHNV9mXZ93zHGSOmKmKYjRmUkYxx0NNKx/3Npx/9atU7kSWuh1Qk8tcj5mx8qZ5NNjsbmcEy4XPPrWtplgY8PMAZD+ntWzFboSOgJrmtbRnRzanPQaTFFGQU+YjqazdQsArFkGMV2y2wdvx4rK1eAJnIOPai7sUnqUNDibcNx3BUzmugjX5Sx7iqOkqBaqwHLc1phCcYByBximnqNLW5csoFWMS+h55xxS3Icxb42LcdBTorY/YWJb5icirFviBGSXCsVA6dq2S01Jbs7lOCKV5ge5q8YWCAHGCefpVhJV3xtsVUOQD7VBcElGAP4Z6UNCvdleMKADyWJNNddpwqqOKieOR5MRnAUU+QH5WwSOeaxV7hYjjRgx3v16YqBI3S63s3A7VKqEuPMJXA5PemXj4YKufqe1S0Nb6BHKXPThjiryoXU7TjttJ60yGArDmIj3zSR4UAhssPTrWsY6GUnqLHCgdd3X09TSiGMSZUfNxz61RnuP3gEZ2up4qdXb7OCT3xkcVTRbiyczRs+0ckHHXvTjMdxVugNULSE+ezHkEg1NIfKBPJ54qUrhy22Ib6bM4iAxHjJqlqEogl3EYBGMU6+kO58HK4GPaqkspkiEco56jjrUNdi4xBiJtkitkAcVQjcC5bfnPXFTtiOLG7APcdjVeSP8AeA7gSwz9KXmaRWo9JTIzKPlGcE1BNMvntn7o6Z70kEZB+XIUsc1Xvo8ShlOV7itFsbKKuSSswMeOnWnzYmgLD5Tnpmog58iNNqly2Qc9B6YqcjJ6ZJG2siZoq+WUj3AH12+9SRAbSQMEfw00EvAecMP1oUMVK8HvTTtqKWo11UMSoxk96rSoSDhunWrbKSAxPQ5qMpiPdxnJxVxRnchilKLJgYxx+FWreb50Gck9DVFR8pP5g07GyYfMOnFTLXcfLdF+9TdMD6nH0qKOE4BP8JOPaiS4CqpJBwefenWsm9HJ6nmodr3ZKTtcttF8iknnH6VUkjV3+UdMjBqykwJTHNVrpxE/3QcnJ+laqyM1caTsXIxgcZqG7bzYlCnjjkVBPcKMDd9arxXJWIr/ABE8UuZdC1F7ss7/ANyV24OaaxBbLAH0pCw6sff8arXDMZDsyFz1qOawctx8siyH5uAOM1WlA2qVXHH5VKsfBB6tTxGvlEnP+FQryYbFCZWYMQOOxNRAYA3enOOtaiqBDggEgZ/Gs6U/v2wOMc1Tb3Gnd2EnUMi4wtMEOFU46GpSCwxjAx+QqUrlQvf2rTcGVHjA54FMY7V3AfSp2BxsIHpTZYR5bfgKVrmbREufLH970q8G/cquAeMEZqovyDIwRnFOZ9pAJPXJNWvd3M5eRNhljTPIXPFMkcyAbxjsB6CnKzspwepP40+UgqizgBiOCP61cWmiGd3HO0ZAcED1qYXqAA7sc9auXFuCTkc1WlsI2U5GCeOnSufVHSkmCaokLAMwOe+az9V1EXChIxkvwKkk0EuSQ5APOau2Okx28m9/mZemaHLuNJE1lCYoo1xkgDNa1vFkbcckZqKPGRgZI61PakiUbjgH9a0hq7gyeOJtnJ+98uB/OpXjTzR3BOGNISE2OwKkHAPpTRKXm3FQTkewrRmZa8tcEDlVPAqtMm1MqMmpn3gux6NzT0KsMHjI6elS3qK/Up6eu9HkkGORj3p0jImC2ME4xUt2DGjiLoBwaw5WlkZRkls1LaWhSXM7mnJtYngZHSq/k+a+XYZ9u1IS4j2nqeRTXVk2847k1S1YloXjEdwXdwB1pPJjjRs8k4PFV0nLSADK9QSO9TnKA564zVIze5nagkcbblCrxxVeO6UxbMHnnFR6wQ6qq569u1UlV3AYk8Dk+lZSk7nRBXjqblmxduDUOoSGIuByR0pLYeV/F8o5BqHUGLck49RVyWmhK+Iz7afzM7xx3FPvRuUBfrn0qAIEmbHRjn8KlnIXIXPIrNLQ0e5WB3xNGSASc81TUbWcS546EdqvSIAwZT07mqz/ADsXXIHf3p2skUixb/dHPJXBJ9ahuI/3j8AqRupY+MnacAZomcbhuPBGBim9dR3sylDGJJOeic1PdkIVJzg9/SiBGEhIxwOR6+lE3zRhZVIIyARWbfQG7sq4Knr8hOc0xHJBGRhh1qSR/k8o4B7dqaoUcbeQefehaDv1Jv4No6+/YVCwOxlxyTVlIyRuPIA6+tRbiCRjNaWMyqIwqEDn3qFy2fp/KrTYCn+EDkj3qJxlVKjAxUOTvoXErSNmMsR6E/4VZgkKoAgIeoIQS3HTpVmMbWDZ6dc96yn2HLYntnILhgAw6VDcqZxnnr+dPtyfMbcfv84FNG7Zx6ZP/wBaley12MmtbooXFs0eB1OOaSNBtXAzk5q025yC3bHWmAbmHtjn3q3azaHdsbdx7RlTuwOgqCRv9HK4ycZ57CrhG6Vyw4JxTLiAqF9CpzSa1dwT7lESM5Vfx47GpZAygD1OSPWnmNICpH8OOPSorlzIzlSMYzkmn3F6BK5RsKR04qnt/ec9c81IDu5IPByaSPh2diSc+nWna6KSsNwVkI9RViJR1GMjjBppwcEfWpoyGU9qbW0SZFe5jxMrAe3FNZcgqcc8jNWZBvkDKePSmSgcGr20RlcobMFhzgnpTZzgjAzzVqRcgmoGTehUnnkj2phJX1EjfbsBJGe/pTrgq3lk5YMOo6iqmXLbc8fyNSFz5I2MMqSMH+dVG+xk9D2jPzOxUAH1HSo2ZN5BI/8Ar0tzgMFBAB7VAUVmGT171i09jpSLBlXAXOAP1pm7LgAnJqCdAI93TuafbNl045IzzSS5nqGy0LkQY4Ug5P6VaiiRl25yQefao4ArEeY2c8BR1q5AgYkKgBH6e5raKsrIi5LANzDHzKem4dMCniNfKxGM5GSaREYNw20ZqzEqhTkjC9Qat7GcmVJHLKpZeAMfWoELiRgxAGO3NXrlQFUDBBqGQoqPgdV4+uah6gnYaw3Rbn5B6j2qijRDAxgnP1qzcNhBwWPA4ps4QIrDA4/WnYdyFApUErkE8fSq1443EKec5AqZ+gKnt0qFAFKjGfc0NW2GkJbY3DI4/rVtzksr5wO1RR/Ic8E092J3fT86d0Q9zLuFAmYFSyjgVDDbMXz90H7xq9Mo+XOSe+KFwobnAfnntWfLdmyehUvJMYXvnrVadwQx54xU7N5nmHJyPyqqWUlTnHOCKV2ykV1BWRe5zT7lSF71IEG4AdqdMrEHoRVWKuUCeg59KIF3ELjuRUyIdoIHSlj+Qg8e9K66jb6IkkQbPu4I61RnQGMEHHPT2rTwGjwByelVfLHlsDjO7I9qPISZAXUOuOoFV5mZ32j+Hv71Yni2rzzzgGmxoPnY5BHHPUVEotDVtyg6ZlUkVMyY3HIOTzRIhzjO3JyCKZhiSTkD0ojoUOjZiCpHJphBALGpQTsC46VDKdqseqgHNVbS7Je4xwMZJyCDyaqvI2MZyF6EU9izIyk4Gc5pC3OMDB6isuZrVlLQiQmN+FGPvCrCOWYbhyewqJOZNvtUhBWZeMe1Z6k3sSLwcjqDwfSkjO+RQehJPFK5AQgHnH61FGdoLdeuacXpqJFieEZAHr0FRCAoc9Mnil8xjGX5wG/KnxN5qBcYbqKqO5OozYcNu65z9ajuH3ZPYjp6U+RwEl3dQMVTDhgR/d4Jo32BK5HM273OOlVJDtww5OeauvGQ5buO3tVWbDFwBge1UrMuJGudufbH0pSvzA9CBT2jaONQOpPX8Kcq7cdwR/kVpFWKvcAAcKPx9qdtxjHSnqm0lux/Onhc4J4I/Wn8TMpMhH3+n0AokXKg9BUhUbgw78UyRT78Hmlr1IW5XYfJn3prKpwB3FTun5GoSuDjFNO2gMoeUVLMxOB3qIgoHPGCOKvygNx2xzVGUbX29s4zWuy0MHc9oucPNgcmgLwBt561IQqnK89RTJNo24P3v0rFdzov0GXEY2ZY9fSooflmV2HHUippSucscdOKahBReByc/hQ1cpaI1UwEAB4JzwOatwybQSQEHTk1ivIfl5YAdh1IqwZAZF/jDYHHatEyOU1/MRwABhe7H1qFLgF3jY4I469ajVkIw7fMOMCmlDNMGgCgDqxP60NkW1L21Tu67+lJOqtnPT9c1DapI4bLBAM4JPWllgDcvIzAHoDSbJtqVbt3Eg2MFxxioXOwZbnPSpGiVELuM/N69RSkmYk7cAdDUXaepdiBtiqTMSB2xVZplaU7Dxjipb5T5RAGSe59aoxWpRyWfjFS5a2RokrXZchc+Z82WI7VZUnEhUDrnn0qGIpFF85+b1p8kypGM5JPANVGVtDNrUilYEbSPm7c1RZ+CpIB7e9W5pPmK5wx56VUkA27hg96Tdnc1iiDBU9TycGklhIXdimyM/mFh0z09alaUyRgbaUdS2mtSBe/qo61P95Cc8dKhRTuLHpVpEAX1p3fUmRUIwMDNQzjOAOD3NXGTHI7ZNRygc/L15FPdEqVmMiVlhHPP8qa4+fmp4/u+2aG4Ymhq7BPUpMuSQenWkkBKn0PU1Mwy/J7cUD7nPfrRuXcoKh3H5c9fwoWPLjIPvVvADEE9P50gAyQOvY+9PoO7KkybNuBwTTZIg0R9O1WpcEYPFVycEgn5elFxO5QlQ8Y7jB9qYsQ6kckd66eLw49zZW919vsoEnUuqy+ZuwGK5O1COqnvSv4TlZTt1bTOOefO/8AjdRKnJ6oj20dmzkUyJD37VbQKSeTnoK6D/hEXMeRqum9eT++/wDjdKvhKVlJGrabwMnHndM/9c6zVKaJdWD2Zzfk7lOOcc5qFQS46e+K6qLwtMpOzV9LYEdD53/xuoj4Y2MzNrGmZPHAn/8AjdU6Ta0Eq0epgtGQdpPy9aWIhZQx5Gea3z4bY4VdZ0zd2yJ//jdRN4ejjIL6zpox6LP/APG6OWS6C9rHuc7OvzE888fjUKrgZ4B711Fx4fRyHTWdNCg85Wf/AONVXPhuPtrembs/3Z8Y/wC/VN09RqqjAnTcG2524yDVL7zhT3GeK6ubQokAxrmmDb/s3H/xqqo0C3jlBbXdLB6/cuP/AI1VcnQqNWKMhuMAg4HpSBAW4HU4+lbLaVZF+Nf03rn/AFdz/wDGqP7Msk5fX9M9sJc//Gq0SD2sF1MrYuOR0p20bQfwq/LDpMRXzfEWmj6Q3J/9o1Gq6QV2r4j07d0/1N1z/wCQaLO5DqL+kUHXBb0o29D1HerrLpCgbvEen5B6iC6P/tGh20WNcSeJNNH/AGxuv/jNLkZPOjNdeQcdc1XZc4b061oSTaDtyfE+mjH/AEwu/wD4xVZrzw6UYDxTpuO+ba8H/tCmoSegc6/pFSRfnbFQzwjGBjK81b+2+GwwP/CVaYP+3a86/wDfipbyC1k0qG/03UrW/tpZpIPMgSVMOgQsCJEU9JF5GR1q4waRnKaueonG0sO3SoXAKlj0PSpDEQTg5DdielA6BPQ1nFI6kuqIPLMmWbpRbD5vmHbAqyqgKfY8U50DBcAAZ6U9geuhAEbpg9Pzp53qhfuMZFSuMZToPUUix5JEhJGetSCCDc4wc4PIP/16GdlJI+mQetSElpPLRSEA6eg9TUkQVspEuVU/ePequK5aLoYxuAYsM5zTJHCqu2Pjp1pBhGJXkn8hQyFyd5CjsBQ9SFuR7i4wVCHHJPODTgYy+GkZmxjGOKYDliMY29T71MEIHBGOhNZtiZXmMQcDaD6H3pAMxnKDJOcntSyxbjnGG96aiMAA3I6Z9qzT1H5EDlnJzjaO1Nk5HD715qaSFhG4yMZwKiVcRliMN0/GqS0sV0uU/mM4XnacgZ7UoRgCex4FTStvcbT+PpSuQ4AHGeaGikyjKhD8c8U5EG7jrjnFWXXAHHGOtMwqHNXa2hpchI+9nB5zxUoUhRzmkj+eQkjoaevKuOu08UlsJkeBt57VHMp8pWx07VK2CoHemtyg/KnFXIaIwdqfTJqIfNyeOORTsEEH8KVwB93t1obBWRE4yzMRg9qgOScHp2qcg4OelMKnnjpxRsVcbt70GPBB7HsKkZeArfpSAZfGPbrRbQCBxuIz0x1qHZ3bv0xV11zGDgDFQOoTaAOB0p6Im50dvuGjaPg8i2bP/f6Wk8s7TyeR09qlgXdpGkPuwfsz59P9dJTS64I25HOfp2q5HJrd27v8xsQCTElSBjGPepNiMWUsSxHT+dVTI3zPuwuQPenLIWZcnA79vwqAsCgYypwOR7VTbGSDwR3NTPnHHIzjryT6CqNzKqP1PTJ96ktIbdMYyNmRzkH2qKR8Jljn1ouJd4GMDv16CqbSjywWYDvtpNDJmlLhQM4HH1qKYvtbB56ZqAztgYxg+npVWe5kYZU9eSR2oXdisSSSkyc5PHBNVp5sAEkZ9KYzF1G8ckDnPaqV5cBY8beTgnApbFpXJZ5cMCMHiq00jSDoOnSonf5VJ5YioriVkCheCeKdyWrEF3CCQ0npnBNQJMmMNhT6AUy6d5T156e1VFVVbBO+Tpx0FW3dDUdNSzIHbleAelVLqFG4kfn2q4+wLktgYHWs+chn3KMgjA96uCdw1Kc0QQFhgnpg1lT7mGNtaV67gYJ5x0B+77VnOpDYDtkcnit4rqJ7amfOCCSOg6mvSPBz7/hzaE9P7VvP/RNpXnF6GKkYIPb0r0bwbG0fw2tA4wx1W8x/35tKqfwsx3kl/Wx7iPmlcj0qAKPnIHPWpYg+w4GCeOabyoHf1rlbO1AAACenrTkbC7iOp4HpTtuFUHrTGT942KIsGQs/OBzjvT45QCT1yMYpjKQjHaKYq4H+9Tb0Hcu/aCEAVf3pGHb1qxbkEcqWc/wrVBVL4xj0I9avRSyIxCFQcAkntSIa0JZmyeAEGMcdqaVJQEnI9agvJV83C7myOp9aeZN7YGFVRjj6UPuTaw1V2yls9D09eKkQZG0Dnjrxmoi53e/HJqYlB3IK96hq+gmxzfeOeCOarPMER3Ayq8Hj8qfcODkHoRwarcbXBPBbp61FtLIaXcC7FB6NVe7YNGWU4fHI96lBO1SRkc1VRMJ8/XpzTNIoIwCwZMhT0pckOR70sZ2qF9O9OZcsCSBkc1SSKGSA71U9hTZEBYfSpkUl1JGSelIY+/403qK+pDEMM2TzTlTr+dOCneuBjj86eMZ55FK1gbKzjtjv19ajcbkJzgg1PKAMCkKYLAjrxQmgKrfeUdBnOKVslm7DNO2ZIJ6nildckDHyjrRuNkXO7FO2hT0yD/OhhluKe3KkDg013IbIXXI+tMIOFIFWODHjvTehXPBPpR1C5FndxntVa4Q7PlPfNW0XDZGM+9QOeGz0H6U2+ojeDFdD0eIICWt359P30mf6UzduBXZx0BzjNQ30hFho2CQRbMR2H+ulqnHOz+ZuJGOQff2qpWuc+uvr+pc3gRM4jZ+cjtjtSmYJEy4yMb+lUzcMxRVcYPB4xUF3Mfm3MeeMDjihtWugjG7sH2o4bzVClcnPrnpVWZ1RE3btzHuOlQzTlnwB0Gfr71XLllVmOXyQfas7o6OXqWZG3seflHQA5yfSqM2HmfBwF4zjjiojNgSlgQgPykdarwl2I3ZxwDz3NVuZNalsLmM5IOfm/CoJtyp8vO/samyfMAbopHygcE1XlOWbeCc+nrTcUJNleYZBydqjn/61U5nVsjHsDVq4GIyT87k4IPr6Vm3QPlgb8bz+lRylXGzyA4w2CfQc1RlnDbhkjbUzZG9udvIB9qoFGd8opz1Iz+po5SkNMj8k9D61DHIOCueTzUkqujliDkevY+tVywkdVCsoA6nv9auKVtR7k0rCUgfdVSB1zzUd5II48R4GxcnI6n2qLBwmHCMevt/jSxxoS+8SSLgjMgwwPpnt68VvTSImuXYyppJGZiAq8jndwKhfc2Cchc/e7n2q/dwRtMFiQxQquMAZLHuc1FcRx28o8sFyg4UHhM9z71b30J16mVLKzp+8CrtbaiY5A7mvSvC6lfh3ZZ6/2neEf9+rSvPniZpDIo5zjkdPwr0nw3GU8B2a8knVLwknr/qrWiesGZ7SX9dD2hk+VBz700x88YqUDJPc5pJQYyOODXIzpI3AHHU5qIofNG0kE8VZPTJ9KYy4O4kcULzG2RuoDYPTFVWXLxqe3p61cYA7iO3QVDKp85W6Y5qkOIW6OrOQRhT+QqSTJGQMKT065pFiImXBwrfrmn3CgAAEkYwB2zUy0C5A5MgUk9DxUrQlWzkgt1pkaEoSMAp/WpwCxAY9B3qbg2RONoGRyDnPWkizNIYt2Mg/MemaRZQQgxlTyR7d6ICAxxgD3qXqJodJuEiqMEYwCfSoWO1c4yCPxqxMTlTgcYP/ANaoQgD7lzt5/LNLrZCjtqMjJIDAZT3qKb5mbGMH+dWXATI5qELu3D04q4ouPcih+YkdGPSp2QsV9cdMdKckYXb6EdRTz0De9N7WBsgVwJSv8SnIpw5yzd6XAyWx1NIeox25xQSQSHbjIpjMfmUZODTjl2A96UphmOelJO7LVkMCsWO4cHpmnkZQHHNBIMeehzTicHt0oBsr4wenFOYfLgDvzTpEyc84PWm5xEMcnvTXkSyu4O3d/KgAn3zT5AfamjOTRpYQgICc+nNNfHApMkKAecfrTgpJ45HWmJ3GhcDmonTkjAw1TklMZwcetRkjIwPzptdx+Zc1MINO0lWJz9lbH/f6Ws2MbYyBls8g5q5rjbbTR+cf6K3/AKOlrNRt0gOc4Has57kQ2+/8xC7LzjDAc+lBYNF83OTTbjIJJGMcHPrVSSXhR8yjt6UrlJaliYqwwDg45IqjK4X5QML3NLJODIFUHaBjnuagl+aMFzx0C96S1HJ2K12+YXVeOBgetLEVwgfOcc47H/CiWNdigqc/3qSKN3fccZA4H0qlfm1JbSRYxuT7zBe1EhOUKBc9T7U3aQibmPGcj1qKZyMjnjk+9W2Y3I7r5UVQP7xIx0B6n8elZFwuQ7kYTIBJ6t7D/CtR1bB35GfeoPLImPT5QQvoPWouikZjAk7GAROu09FA9agd1ZsLhI+pJ6mrt2pXCoMqDnHofX3rNuId+FZCADnPcn6073LST3EeAs4cKWVvmAz0+tVpY3+cMdx4LbR90elaO7YoVyQz9eP0FQXiERRBcEAk/KeCc9PcitIq+o0yK1iCnzGUeWq5IPUHsPrTY5Ht7qOUyxyur5PmLlfpj0qW2inlZHdw4yd0hHAOOppm2VU80oGYZ2Aj5cj+In0HNbCauypeR/ZpdsmHlLHG04VQe49eOlZt9CsMjomfmw5JPYjrVwxfaFZxukjb/loT95vb0qqYpS/lPtyOZHI6UJdxWt1K8StsWQEdeM16D4WYv4CtSfm/4ml5z6/urXmvPLxlJ8tDgKMYH+etei+FojB8PLMMD82pXbD/AL9WtE5aNIhrVM9pj4dx/nNLMvygY4oUFeV7nNOY5XB+tczNiIj5SBycVEvzqPXuKnb5cccYyaaigAn1JzVR1FIjH3eQc54pJFPbOMc1JGPlDEcDtTlGWYdDxTehS0IcszxqeCvSny/wlu3GKG5fHemXB80KSegzTvpqDQsbBmKjjIxj0NPVQ3DNkY6/jVcL82V4OMc1GXZUxnBPOahtdB8tx0qgOdoIzxikQgMS3QnOaieR94Hock0zzcnnv+RrK9h8pPJKSWweAcLTUlJj9FzxVYjDdcqDnFTDggHOOlNLqNIcSSeT+dOjXAJJxmnDlemcUoXC57jrWnQNiQKDjFJtHA9MmkXKqwx1pwyBvAPPGTRstSBr48tRxxzmoSADk5FSKcx4x0NMc5579RStcREFBfIPIz9KACEOe4pUU55yDSsDgbhSemxQxUzmlC84PT1pw+9x0Pakc/K3rS9AGEElgewpkeVXkdRRIWJwMccEVMmCvPXFWu4mVSoYDPXOaUoCcDj0pZVAzjtQfukHJ/rQgKzj5sjgHipQMFRkEY6U2RRsAzxTk+4M8kU9RsjmA3c96rkH73IGKtyAFcjPFQ7evuKVyS5fxh7LRwyEkWzcjt++lpiQQQqXwPm6VbnLrBpPCsv2Nwcn/ptJVVp0S0SEMhdBIzHIPXhR9MU2tbmaV/xKd3FHOCzKdi+nb/69VPsqMNzoS2Mg54qyriSJlA+RYtgIPBYnIP6UO2EjZ1b5Rk7sY/Ckoq9xtNaFSSFWJZkVVwevpVGZASrJHg9fZRV26ljllGAEzztU9qp+cqsVK5wOB3zSasTuRSk+bgEfKMgdjTQxZSq4VSOMelJK6qPm4cnrUReIMgDfMTgCobZfs2lciumPVzhR0FUp5ZGbO3aBwCT1rRlKvglDnvxUE21yF25x0BHAqBJorRuyjDHe1RPKFJ3nBA6ds1PPIIkwMFvWspoGfzN0pYnk4HSga1IpZzI7HdtA4X3qtPNMjRLEN2DyxHC1YMECNltzkdADxUkTscKoVR9M1d0ncLpbEsNr9oVWY8v3I6VM1msJURhd23Yox+v1PrVmwU71B9M1ZuSSVEKhpT93jhferjJmfNrYwfJmiDR7tpHzPgYxnoMevWq80ZZXG4CJV28jAP8A9YVpXmCoiaQbEOWZvvM3pn/OKyLqcLbspYifOAgHy47D3raLbL5upmXU3KBF2ov3ABjn+8apzzPgogODyzHqTVhmdgQVyW/E59Kuw2DHaz7cAfMT1zU3Y2jPtLIKN+OTXfaUAvgWwAP/ADEbv/0VbVyz7FUoBnHc11WlgN4Fs8D/AJiN3x/2ytqLuzFO2h7EOOfQU0vk7ScMOaDnfweD603GXDAdKlOxoh2RtPHSjaQCTyO1B4kJ7HsKeBlSaNiHuQB8OB271LGMEY6mhgrMDjNDHBDDqBRfWxZA3XI/Gk7nA5/pUpXKnvnvSL8x6D60XdtAI2AwFPUcVAF+Y59/pVqRTuGOgpkqEE4HTmk9QTKroWGCPaoCuCF9KuSYyc9etV8FivFQ1fc0uMKAdfSpDjeOBmnY5K46d6VY9ze+KdrBceBgDA465pyHsRxQqkKWB5A5zQvJQkYOM49aZLY8qdh4pgOQ3pT0Ydzj1qLd6Dg8/WgkDhRxjNMfoTj8KJBg+xANRliSBnikvIGPBzu7ioy2UIPWpGACKOhpDg7cDHvQBCzHII780jEng1KQuBxnFRuu38Tz9aWpStYYPmc9uM1J8vIHcUzjK459qeTgY7Z6032ENYDHbNNYDZu/MU6QHK7TyTTB94jt3pvcREU3ZBIPpx2p2RkjHBFKM54x0pucg+3pT1B9iN8gewNR8jp+NTuo24J/Ko1wx564otoDLmobWs9ILgEJbOx+bn/XS9qwJiFi8xQrdCwRcEHPGa19cOLXSMbgwtmJA9PPlx/n2qhGzKkZUjdng9ckdAfWtdLBF2j/AF3K6R91fkjJB9fan7Gw5yQ23adtE9vMUbBCuRzt42/h/SmhmUGN2wAMcD9ahibutDPuJPLlMbqWL9GPBAFQxKGIcRnOc9elX7raIi4UcttXPYAdTVdpwGjCqpJByemB6D0qdOpKfVIqPGj+YZVcbHCpk8Y6ninBoM7toyvy89hVaeYsQoAzj1NEVvujLNIRn09Ki7ltsVOdy1LdJ/ARnGdo7mqUju0eNu0nvUgiijCkDAPKg9SfWkaRERnkxnGAPeixj5ozZA0cuD83f61BcNuJCkDj9ammuVlkPyt6DiniESAYXgrnB9KixTbKZiAUHlgRxjvUkMcrMAExyBWklqSF3Nj0A71YVBEAABz2oZLaKsQ8puCC5OT6Cp532xOR8mQee/8A+uo5VkVt3Gf0z6VWkLGLIJdi3BHXNaRVwaW5VlVGwGxuAwMdR9PeqF1bfvGCIUIHJP8ACP8AE1olViw27MpHJHRfpVSVvO2gMSqnJUc8+p9armstCoq7K9laqjE7ckdDnrVqWNQowvB61a8naByAcYwKqygqCvU+3ek9C3oZd4wJx3H8q6jSW3eBbQjJ/wCJldj/AMhWtctepxuPUfpXRaU2PAVmAeP7TvMY/wCuVrWsV7rIbTaPbEO5e1K2NoJoA2YHbH5U1hkr6A5qDQZ91VAyAO9SFtuOm3rTGUtj6Urj939B0qidx6gNn6HrTSuOn0psW4YB5J4pwJLnI4FSUIDk8Hp1FKMc03GGO3r60/BHPbpilcGMwSwGPl60gXDknlcd6cB8x5560pG5hntzip2GQyIGJK9QMVWwN4Gast2Cnn+dR+V8zEdOx9KoaZGp2kDHXrUsagYJ+8TSxlSSGHtQvO5ugHFJag2Obr04qInD7h0xjNTgBowR0HGKiZco2eATxTvcRGCRuBPIo24GCMEjNJg7hnp3p64cMD1xjFSwIcltwOOBVeXK5ZeRnirQTg561Ceu0jjHOKaQXE8zO0kcZHNPU5YnmohjAVgeDUw+XgGk/MQxS2AO+TUb/ePHOaldgJD64qJhk5B5z0pLQrqMBGQcHHapSRkDIyRUQGDz2qQ4I471S0BkJJIIHSjdkjsc4pQAM56GmhuRxQtwDq3cDtTGJAC/hmrDLhcbccdagkx6ZyOKLiWpK33Pm6/zqDbzlcHmpCcryetCkDIpruIZrNoLi10p3fAFqygZ6/v5f0rNaHYQ4H3F+UemPSuivrG9nsNLa0sbq4X7Myl4omcA+bLxwPeqUekauYwraVfYHGDbuf6VbUmYc6XXv+ZlBzICAMyY4DHGP8TUahY5vLVmLY5J6Z/wrSfRdXEpY6VfbQOQts/J9uKrXeia4ytt0vUcn0tn4A9eKEm1sWpx2uY00m98P0HLHOO9VJZkJYEEALhcdTWs3h7XZIMHSNRGcFQLVwV/SmjwtrAjQf2RqRHRf9GfIHc9OKHDQpzhbcyY1DkKUAIGWIH86DJglSvA/wAitj/hHdbVdo0fUgg64tZOn5VTn8P687ZOiaoSTn/j0k4/So5H2MXOPczZXZmGSAVHOO3/ANequC4CAYUc8+vc1sR+GddbO3RNUAzyWtJOf0p//CLa7tYvo+pM2en2WT/CnyvsHMu5iR2qNtGAqDsan3LGwZc59O3tWjJ4a8QKTt0TU8e1rIefypYfC+vMTu0bUwPe1k6flU8r7Dc13M6N2YEHPr+FSDKgu3JA49q1G8N62pwui6ntx/z6ydfyqGTw14glfb/Y+p7fe1k/wqOWXYV0+piXNyzcYJBHB9vakjdyjblAVuMjjP8A9atz/hD9ccBW0jUQT3+zPx+lTt4T1sKn/Eq1EqDyv2V+f0qlGdtik4JbnKpZzO+5sEdgOgFWorVLZjsVfmOTXSL4Z1pCSmj6iM/9Or/4VBP4a1xyM6LqnHcWkn+FXGDXQbmnszmZ2IlP9apXDgNlGAf0rbufDPiJZS40DWGHtZyE/wAqoyeFvEpY48O6wff7DL/8TT5G9bBzxa1ZympyNlhnknvXQ6TJs8AWWec6pef+irSql94O8UyHI8N62fpYyn/2Wr93pGo6H4D0eHVrK5sp59RvZViuIzG+zy7YAkEZHKmtuW0Xchzi5JJ/1Y91l+6D3pjcx57k0UVibjh6dsZowDJz6UUU+oxp/wBZ9BxQCdxHaiiiWwuo8Abz7U09RRRWb2GxF++KB0zkkgmiikJEf3sE+uKQtlfTkjiiim9yluI3CcADinoAUZT93riiim9gY3oCB0HNL1ypAxkUUVC3AglOJRj1IpttyDn3ooq0Jjm5kH1qmjEvz34oopfaKWwo++p9RT34wR3oopMkjQby26mH7p+tFFKWlikIPmfB9KlIAb9aKKoCs/cetSRgeV+dFFDF0Hn77f7tQuBtQ0UUPYENYYXPoKaeDx3oopdRMV1G8UwAMWJHNFFAkRk/KKQkg/gaKKcSeoo5xQyhScUUVp1AjIAB4FNcDbuwMn2oopLZlkbHGcY6elR5zgnHX0ooqWJ7Av3+3NRynkcDmiiiWwluNLHzAvGMUpY8jjGcUUVXQkqufkP1qCToPaiitLKwdSuWOSO2az7mRiQCeKKKiOwIzLmRhnmqMsrFiDjGQKKKplSIWbPGB69KrzO2RyeetFFDJe5//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sclerotic lesions of morphea with overlying hypopigmented, finely wrinkled skin are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Morphea with features of lichen sclerosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 422px; height: 422px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lichen sclerosus (indicated by arrows) overlying a plaque of linear morphea (hyperpigmented plaque with dermal atrophy cliff drop border).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24805=[""].join("\n");
var outline_f24_14_24805=null;
var title_f24_14_24806="Alendronate and cholecalciferol: Drug information";
var content_f24_14_24806=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Alendronate and cholecalciferol: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?42/12/43205?source=see_link\">",
"    see \"Alendronate and cholecalciferol: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F10911805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      FDA Review of Long-term Bisphosphonate Efficacy for Osteoporosis",
"     </span>",
"     <span class=\"collapsible-date\">",
"      May 2012",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       In response to serious postmarketing adverse reactions, including atypical femur fractures, osteonecrosis of the jaw, and esophageal cancer, and a paucity of long-term efficacy data, the FDA conducted a systematic review of long-term bisphosphonate therapy for osteoporosis. To date, randomized controlled trials have shown that bisphosphonate therapy is effective in preventing fractures in trials of 3- to 4-years duration. Therefore, to examine long-term efficacy, three long-term extension trials (involving postmenopausal women) ranging in a duration of treatment from 6-10 years were used in the FDA&rsquo;s analysis. Based on the available long-term clinical trial data, the FDA was unable to identify subgroups of patients who are more likely to benefit from therapy beyond 3-5 years. Continuation of treatment should be based on individual assessment of risks, benefits, and preferences of patients and their physicians.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Until further data are available, the data suggests patients at low risk for fracture (eg, younger patients without a fracture history and bone mineral density [BMD] approaching normal) may be good candidates for discontinuation of therapy after 3-5 years. Patients at increased risk, such as older patients with a history of fracture and a BMD in the osteoporotic range, may benefit from continued therapy.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Further investigation into the risks and benefits of long-term therapy, the usefulness of markers of bone turnover or BMD in determining duration or interruption of therapy, and surveillance or fracture risk after therapy discontinuation are needed.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       For additional information, please refer to file://www.nejm.org/doi/pdf/10.1056/NEJMp1202619.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F596002\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Fosamax Plus D&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F2933972\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Fosavance",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F595968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Bisphosphonate Derivative;",
"     </li>",
"     <li>",
"      Vitamin D Analog",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F595992\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Osteoporosis:",
"     </b>",
"     Oral: One tablet (alendronate 70 mg/cholecalciferol 2800 units",
"     <b>",
"      or",
"     </b>",
"     alendronate 70 mg/cholecalciferol 5600 units) once weekly. Appropriate dose in most osteoporotic women or men: Alendronate 70 mg/cholecalciferol 5600 units once weekly. Supplemental calcium and vitamin D may be necessary if dietary intake is inadequate.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F2508494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F595993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     35-60 mL/minute: No adjustment needed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;35 mL/minute: Not recommended.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F4088746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Alendronate: None necessary. Cholecalciferol: May not be adequately absorbed in patients who have malabsorption due to inadequate bile production.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F595999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Fosamax Plus D&reg; 70/2800: Alendronate 70 mg and cholecalciferol 2800 units",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Fosamax Plus D&reg; 70/5600: Alendronate 70 mg and cholecalciferol 5600 units",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F595966\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F11441251\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM241521.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM241521.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F595995\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Alendronate must be taken with plain water (6-8 oz) first thing in the morning and &ge;30 minutes before the first food, beverage, or other medication of the day.  Do not take with mineral water or with other beverages. Patient should be instructed to stay upright (not to lie down) for at least 30 minutes and until after first food of the day (to reduce esophageal irritation).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F595969\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of osteoporosis in postmenopausal females; increase bone mass in males with osteoporosis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F7254243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Fosamax Plus D&reg; may be confused with Fosamax&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F595979\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F595973\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to alendronate, other bisphosphonates, vitamin D derivatives, or any component of the formulation; hypocalcemia; abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia; inability to stand or sit upright for at least 30 minutes",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F595974\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bone fractures: Atypical femur fractures have been reported in patients receiving bisphosphonates for treatment/prevention of osteoporosis. The fractures include subtrochanteric femur (bone just below the hip joint) and diaphyseal femur (long segment of the thigh bone). Some patients experience prodromal pain weeks or months before the fracture occurs. It is unclear if bisphosphonate therapy is the cause for these fractures, although the majority have been reported in patients taking bisphosphonates. Patients receiving long-term (&gt;3-5 years) therapy may be at an increased risk.  Discontinue bisphosphonate therapy in patients who develop a femoral shaft fracture.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bone/joint/muscle pain: Severe (and occasionally debilitating) bone, joint, and/or muscle pain have been reported during bisphosphonate treatment. The onset of pain ranged from a single day to several months. Consider discontinuing therapy in patients who experience severe symptoms; symptoms usually resolve upon discontinuation. Some patients experienced recurrence when rechallenged with same drug or another bisphosphonate; avoid use in patients with a history of these symptoms in association with bisphosphonate therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal mucosa irritation: May cause irritation to upper gastrointestinal mucosa. Esophagitis, dysphagia, esophageal ulcers, esophageal erosions, and esophageal stricture (rare) have been reported with oral bisphosphonates; risk increases in patients unable to comply with dosing instructions. Use with caution in patients with dysphagia, esophageal disease, gastritis, duodenitis, or ulcers (may worsen underlying condition). Discontinue use if new or worsening symptoms develop.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Osteonecrosis of the jaw (ONJ): ONJ has been reported in patients receiving bisphosphonates. Risk factors include invasive dental procedures (eg, tooth extraction, dental implants, boney surgery); a diagnosis of cancer, with concomitant chemotherapy or corticosteroids; poor oral hygiene, ill-fitting dentures; and comorbid disorders (anemia, coagulopathy, infection, pre-existing dental disease). Most reported cases occurred after I.V. bisphosphonate therapy; however, cases have been reported following oral therapy. A dental exam and preventative dentistry should be performed prior to placing patients with risk factors on chronic bisphosphonate therapy. The manufacturer's labeling states that discontinuing bisphosphonates in patients requiring invasive dental procedures may reduce the risk of ONJ. However, other experts suggest that there is no evidence that discontinuing therapy reduces the risk of developing ONJ (Assael, 2009). The benefit/risk must be assessed by the treating physician and/or dentist/surgeon prior to any invasive dental procedure. Patients developing ONJ while on bisphosphonates should receive care by an oral surgeon.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal malabsorption syndrome: Increased doses of vitamin D supplementation may be required in patients with GI malabsorption syndrome; consider monitoring 25-hydroxy vitamin D levels.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypercalcemia: May exacerbate hypercalcemia and/or hypercalciuria in certain disease states (eg, leukemia, lymphoma, sarcoidosis); monitor serum and urine calcium levels.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypocalcemia/vitamin D deficiency: Before therapy initiation hypocalcemia and/or vitamin D deficiency must be corrected; ensure adequate calcium and vitamin D intake. Do not use to treat vitamin D deficiency.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment (not recommended for use in patients with Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;35 mL/minute).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298702\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F595984\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aluminum Hydroxide: Vitamin D Analogs may increase the serum concentration of Aluminum Hydroxide. Specifically, the absorption of aluminum may be increased, leading to increased serum aluminum concentrations.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: May enhance the hypocalcemic effect of Bisphosphonate Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May decrease the serum concentration of Bisphosphonate Derivatives. Management: Avoid administration of antacids containing polyvalent cations within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Magaldrate; Sodium Bicarbonate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aspirin: May enhance the adverse/toxic effect of Alendronate. Specifically gastrointestinal adverse events.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bile Acid Sequestrants: May decrease the serum concentration of Vitamin D Analogs. More specifically, bile acid sequestrants may impair absorption of Vitamin D Analogs. Management: Avoid concomitant administration of vitamin D analogs and bile acid sequestrants (e.g., cholestyramine). Separate administration of these agents by several hours to minimize the potential risk of interaction. Monitor plasma calcium concentrations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Salts: May decrease the serum concentration of Bisphosphonate Derivatives. Management: Avoid administration of oral calcium supplements within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Salts: May enhance the adverse/toxic effect of Vitamin D Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Vitamin D Analogs may enhance the arrhythmogenic effect of Cardiac Glycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Danazol: May enhance the hypercalcemic effect of Vitamin D Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Bisphosphonate Derivatives may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Salts: May decrease the serum concentration of Bisphosphonate Derivatives. Management: Avoid administration of oral iron supplements within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ferric Gluconate; Ferumoxytol; Iron Dextran Complex; Iron Sucrose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Salts: May decrease the serum concentration of Bisphosphonate Derivatives. Management: Avoid administration of oral magnesium salts within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mineral Oil: May decrease the serum concentration of Vitamin D Analogs. More specifically, mineral oil may interfere with the absorption of Vitamin D Analogs. Management: Avoid concomitant, oral administration of mineral oil and vitamin D analogs. Consider separating the administration of these agents by several hours to minimize the risk of interaction. Monitor plasma calcium concentrations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May enhance the adverse/toxic effect of Vitamin D Analogs.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May decrease the serum concentration of Bisphosphonate Derivatives. Specifically, polyvalent cation-containing multivitamins may decrease the absorption of orally-administered bisphosphonate derivatives. Management: Avoid administration of polyvalent cation-containing multivitamins within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the adverse/toxic effect of Bisphosphonate Derivatives. Both an increased risk of gastrointestinal ulceration and an increased risk of nephrotoxicity are of concern.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Orlistat: May decrease the serum concentration of Vitamin D Analogs. More specifically, orlistat may impair absorption of Vitamin D Analogs. Management: Monitor clinical response (including serum calcium) to oral vitamin D analogs closely if used with orlistat.  If this combination must be used, consider giving the vitamin D analog at least 2 hrs before or after orlistat.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Bisphosphonate Derivatives may enhance the hypocalcemic effect of Phosphate Supplements.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Proton Pump Inhibitors: May diminish the therapeutic effect of Bisphosphonate Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sucralfate: Vitamin D Analogs may increase the serum concentration of Sucralfate. Specifically, the absorption of aluminum from sucralfate may be increased, leading to an increase in the serum aluminum concentration.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SUNItinib: Bisphosphonate Derivatives may enhance the adverse/toxic effect of SUNItinib. Specifically, the risk of osteonecrosis of the jaw may be increased.  Management: Monitor for development of osteonecrosis of the jaw in patients receiving sunitinib and bisphosphonates.  Avoid invasive dental procedures if possible.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: May enhance the hypercalcemic effect of Vitamin D Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin D Analogs: May enhance the adverse/toxic effect of other Vitamin D Analogs.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F595985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F595970\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F595971\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies have shown delays in delivery and fetal/neonatal death (secondary to hypocalcemia). Bisphosphonates are incorporated into the bone matrix and gradually released over time. Theoretically, there may be a risk of fetal harm when pregnancy follows the completion of therapy. Adverse events were observed in animals when high maternal doses of vitamin D were administered during pregnancy. Vitamin D crosses the placenta but the transfer to the fetus from the mother is low. Maternal supplementation has not been shown to affect pregnancy outcomes. Vitamin D requirements are the same in pregnant and nonpregnant females (IOM, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F595972\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cholecalciferol enters breast milk; excretion of alendronate in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F595994\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ensure adequate calcium and vitamin D intake; supplemental calcium should be provided in patients whose dietary intake is inadequate. Recommended intake of vitamin D is 400-800 units daily (provided in once-weekly dose of Fosamax Plus D&reg; 70 mg/ 2800 units or 70 mg/ 5600 units, respectively) . Women and men &gt;50 years of age should consume 1200-1500 mg/day of elemental calcium and 800-1000 units/day of vitamin D. Wait at least 30 minutes after taking alendronate with cholecalciferol before taking any supplement. Must be taken with at least 6-8 oz. plain water first thing in the morning and at least 30 minutes before the first food or beverage of the day. Administer with plain water only; do not administer with mineral-enriched water.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F3422178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Fosamax Plus D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     70-2800 mg-unit (4): $131.90",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     70-5600 mg-unit (4): $131.90",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F595997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Bone mineral density as measured by central dual-energy x-ray absorptiometry (DXA) of the hip or spine (prior to initiation of therapy and at least every 2 years); annual measurements of height and weight, assessment of chronic back pain; serum calcium and 25(OH)D; may consider monitoring biochemical markers of bone turnover",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F595990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium (total): Adults: 9.0-11.0 mg/dL (2.05-2.54 mmol/L), may slightly decrease with aging",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphorus: 2.5-4.5 mg/dL (0.81-1.45 mmol/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     25-hydroxyvitamin D: 10-80 ng/mL (higher during summer)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4301378\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Adrovance (FR);",
"     </li>",
"     <li>",
"      Dronalen Plus (AU);",
"     </li>",
"     <li>",
"      Fosamax Plus (AR, CL, CN, CR, GT, HK, ID, KP, MX, MY, NI, NZ, PA, SG, SV, TH, TW);",
"     </li>",
"     <li>",
"      Fosamax Plus Once Weekly (AU);",
"     </li>",
"     <li>",
"      Fosavance (AT, BE, BG, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HN, IE, IL, IT, MT, NL, NO, PH, PT, RU, SE, SK, TR);",
"     </li>",
"     <li>",
"      Marvical (UY);",
"     </li>",
"     <li>",
"      Maximus (PE);",
"     </li>",
"     <li>",
"      Osficar Plus (CO);",
"     </li>",
"     <li>",
"      Osteofort Plus (DO);",
"     </li>",
"     <li>",
"      Osteoplus D (EC)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F595988\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F10143545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Assael LA, &ldquo;Oral Bisphosphonates as a Cause of Bisphosphonate-Related Osteonecrosis of the Jaws: Clinical Findings, Assessment of Risks, and Preventive Strategies,&rdquo;",
"      <i>",
"       J Oral Maxillofac Surg",
"      </i>",
"      , 2009, 67(5 Suppl):35-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/14/24806/abstract-text/19371813/pubmed\" id=\"19371813\" target=\"_blank\">",
"        19371813",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      IOM (Institute of Medicine),",
"      <i>",
"       Dietary Reference Intakes for Calcium and Vitamin D,",
"      </i>",
"      Washington, DC: The National Academies Press, 2011.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Management of Osteoporosis in Postmenopausal Women: 2010 Position Statement of The North American Menopause Society,&rdquo;",
"      <i>",
"       Menopause",
"      </i>",
"      , 2010, 17(1):25-54.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/14/24806/abstract-text/20061894/pubmed\" id=\"20061894\" target=\"_blank\">",
"        20061894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Osteoporosis Foundation, &ldquo;Clinician&rsquo;s Guide to Prevention and Treatment of Osteoporosis,&rdquo; Washington, DC, 2010. Available at  file://www.nof.org/files/nof/public/content/file/344/upload/159.pdf",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ruggiero SL, Mehrotra B, Rosenberg TJ, et al, &ldquo;Osteonecrosis of the Jaws Associated With the Use of Bisphosphonates: A Review of 63 Cases,&rdquo;",
"      <i>",
"       J Oral Maxillofac Surg",
"      </i>",
"      , 2004, 62(5):527-34.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/14/24806/abstract-text/15122554/pubmed\" id=\"15122554\" target=\"_blank\">",
"        15122554",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sellmeyer DE, &ldquo;Atypical Fractures as a Potential Complication of Long-term Bisphosphonate Therapy,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2010, 304(13):1480-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/14/24806/abstract-text/20924014/pubmed\" id=\"20924014\" target=\"_blank\">",
"        20924014",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shane E, Burr D, Ebeling PR, et al, &ldquo;Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research,&rdquo;",
"      <i>",
"       J Bone Miner Res",
"      </i>",
"      , 2010, 25(11):2267-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/14/24806/abstract-text/20842676/pubmed\" id=\"20842676\" target=\"_blank\">",
"        20842676",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8975 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.167.4.114-B39C775BF0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24806=[""].join("\n");
var outline_f24_14_24806=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10911805\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F596002\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2933972\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595968\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595992\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2508494\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595993\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4088746\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595999\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595966\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11441251\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595995\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595969\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7254243\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595979\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595973\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595974\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298702\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595984\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595985\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595970\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595971\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595972\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595994\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3422178\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595997\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595990\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4301378\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F595988\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10143545\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8975\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8975|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?42/12/43205?source=related_link\">",
"      Alendronate and cholecalciferol: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_14_24807="Oocyte donation for assisted reproduction";
var content_f24_14_24807=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Oocyte donation for assisted reproduction",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/14/24807/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/14/24807/contributors\">",
"     Mark V Sauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/14/24807/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/14/24807/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/14/24807/contributors\">",
"     William F Crowley, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/14/24807/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/14/24807/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/14/24807/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oocyte (egg) donation is an integral part of modern assisted reproductive care. Originally offered to women with primary ovarian insufficiency (premature ovarian failure) or those who had genetic diseases who did not want to transmit the gene defect to their offspring, donated oocytes are now used by women with many reproductive disorders and commonly by women in later reproductive years [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/1\">",
"     1",
"    </a>",
"    ]. Approximately 17,000 attempts at pregnancy using in vitro fertilization (IVF) with donated oocytes are initiated annually in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Oocyte donation is at present the only effective therapy for the treatment of infertility in women with ovarian failure and for the vast majority of women of advanced reproductive age. Details of the IVF procedure are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37770?source=see_link\">",
"     \"In vitro fertilization\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORICAL MILESTONES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Embryo donation has been practiced by veterinarians for many years, and is now routinely used for breeding endangered animals and in commercial animal husbandry [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/3\">",
"     3",
"    </a>",
"    ]. Animal experimentation preceded attempts at both oocyte and embryo donation in humans.",
"   </p>",
"   <p>",
"    The first human pregnancy resulting from oocyte donation was reported in 1983 in a woman who was ovulatory (and therefore did not require hormone replacement), but infertile [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/4\">",
"     4",
"    </a>",
"    ]. The pregnancy ended in spontaneous abortion. Four months later, the first successful pregnancies from oocyte donation were reported in two women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/5\">",
"     5",
"    </a>",
"    ]. Again, both women had normal ovarian hormonal secretion and therefore a normal endometrium.",
"   </p>",
"   <p>",
"    Soon thereafter, a successful pregnancy was achieved in a woman with ovarian failure, who required estrogen and progesterone to prepare the endometrium to receive the ovum [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/6\">",
"     6",
"    </a>",
"    ]. Estrogen and progesterone were administered in a manner that mimicked the natural ovulatory cycle prior to conception, and were continued through the first trimester to support the developing pregnancy.",
"   </p>",
"   <p>",
"    During the next few years, refinements in oocyte donation continued, and efficacy improved [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. The refinements included:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Collection of oocytes from the donor using a guided ultrasound method instead of laparoscopy or uterine lavage.",
"     </li>",
"     <li>",
"      Administration of gonadotropin-releasing hormone (GnRH) agonists or antagonists to the donor and recipient (in women with ovarian function) to facilitate synchronization of the donor's cycle with that of the recipient.",
"     </li>",
"     <li>",
"      Recruitment of young donors to enhance the quality and quantity of oocytes obtained.",
"     </li>",
"     <li>",
"      Better techniques for embryo cryopreservation, which allows multiple transfers from any single oocyte donation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A major breakthrough occurred in 1989 when oocyte donation was used to address the question of age-related infertility [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. Today, birth rates exceeding 50 percent per embryo transfer are typically reported in women in their forties and fifties [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/1\">",
"     1",
"    </a>",
"    ], suggesting that the decreased fecundity and increased pregnancy wastage associated with aging was due to problems with the ovary (oocyte) rather than the uterus (",
"    <a class=\"graphic graphic_figure graphicRef53489 \" href=\"UTD.htm?24/14/24814\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oocyte donation has been used to achieve pregnancy by women with many reproductive disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/1\">",
"     1",
"    </a>",
"    ]. The American Society of Reproductive Medicine has endorsed the following indications:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary ovarian insufficiency (premature ovarian failure) or gonadal dysgenesis",
"     </li>",
"     <li>",
"      Avoidance of genetic disease transmission",
"     </li>",
"     <li>",
"      Diminished or absent ovarian function",
"     </li>",
"     <li>",
"      Persistent poor oocyte quality during assisted reproductive technologies",
"     </li>",
"     <li>",
"      Advanced reproductive age (&gt;40 years)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Presently, perimenopausal and menopausal women, and women who have failed traditional approaches to fertility, represent the majority of women treated [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H684709401\">",
"    <span class=\"h2\">",
"     Special considerations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H684709409\">",
"    <span class=\"h3\">",
"     Turner syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with Turner syndrome are potential candidates for IVF with donor oocytes. However, these women, who often have cardiovascular anomalies, have a high rate of cardiovascular mortality during pregnancy due to aortic dissection. Therefore, before attempting to become pregnant, women with Turner syndrome should undergo a complete medical evaluation, with particular attention paid to cardiovascular and renal function, as recommended by the American Society of Reproductive Medicine [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/63/14329?source=see_link&amp;anchor=H20#H20\">",
"     \"Management of Turner syndrome (gonadal dysgenesis)\", section on 'Fertility'",
"    </a>",
"    .)",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H684709472\">",
"    <span class=\"h3\">",
"     Advanced reproductive age",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, the majority of women undergoing IVF with donor oocytes are women of advanced reproductive age, a population at higher risk for pregnancy complications, particularly in the setting of multiple gestation. The American Society of Reproductive Medicine recommends that only one to two embryos be transferred to recipients, in order to minimize multiple gestation rates, while maintaining high pregnancy rates. In cases where high quality blastocysts are obtained, a single embryo transfer should be considered [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DONOR SELECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oocyte donors have usually been recruited in the community and traditionally been unknown to the recipient. In most metropolitan areas, oocyte donors are paid, with payments varying from $2500 to $8000. Outside the United States, however, remuneration is frowned upon, and is illegal in many places [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/16\">",
"     16",
"    </a>",
"    ]. Matching a donor to a recipient is usually based upon phenotypic similarities between the women.",
"   </p>",
"   <p>",
"    Occasionally, women offer to donate oocytes for a recipient known to them [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/17\">",
"     17",
"    </a>",
"    ]. Other known donors are siblings and more rarely daughters who have provided oocytes for their postmenopausal, remarried mothers [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most donor programs seek 21 to 34 year-old women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/19\">",
"     19",
"    </a>",
"    ]. This upper age limit lessens the need for amniocentesis or chorionic villous sampling if the recipient becomes pregnant. Many centers also prefer to use donors of proven fertility [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/20\">",
"     20",
"    </a>",
"    ]. This preference is based upon the premise that women who have not been pregnant may be infertile.",
"   </p>",
"   <p>",
"    The screening of donors at most centers and recommended by the American Society for Reproductive Medicine includes assessment of physical and mental health and risk for infectious diseases.",
"   </p>",
"   <p>",
"    In 2005, the United States Food and Drug Administration (FDA) became responsible for regulating infectious disease testing of all oocyte donors. Serological tests for syphilis, hepatitis B core antibody and surface antigen and hepatitis C, and",
"    <span class=\"nowrap\">",
"     HIV-1/HIV-2",
"    </span>",
"    infections are required [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Tests must be performed in a laboratory using tests that are FDA-approved for donor screening. Additionally, under the new guidelines the physical exam and serum and cervical samples for gonorrhea and chlamydia must be performed within 30 days of oocyte retrieval. False positive results exclude donor participation and retests or confirmatory status tests are not allowed to overturn false-positive results. Written documentation of eligibility for donation is now required to meet the FDA regulation.",
"   </p>",
"   <p>",
"    Rh testing is also done, and the couple and donor commonly are Rh matched. Specific genetic testing is performed for patients and donors at risk for genetic illness, such as cystic fibrosis and spinal muscular atrophy in Caucasians, sickle cell trait in Blacks, and hemoglobinopathies in Asians.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H584065701\">",
"    <span class=\"h1\">",
"     CURRENT APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oocyte donation is typically accomplished by synchronizing the menstrual cycle of the infertile woman with a hyperstimulated cycle of a donor (",
"    <a class=\"graphic graphic_figure graphicRef75520 \" href=\"UTD.htm?27/35/28210\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H443952\">",
"    <span class=\"h2\">",
"     Donor",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3520646\">",
"    <span class=\"h3\">",
"     Protocol",
"    </span>",
"    &nbsp;&mdash;&nbsp;The donor undergoes the following procedures:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ovarian hyperstimulation with gonadotropins followed by monitoring of the follicular response. The latter is usually accomplished by serial measurements of serum estradiol and frequent transvaginal ultrasonography of the ovaries. The exact stimulation protocol may vary from center to center. In general, there has been a shift to protocols that are associated with a lower risk of ovarian hyperstimulation syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22647?source=see_link\">",
"       \"Prevention of ovarian hyperstimulation syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Oocyte recovery is typically performed by transvaginal ultrasound-guided needle aspiration (",
"      <a class=\"graphic graphic_picture graphicRef82492 \" href=\"UTD.htm?11/23/11647\">",
"       figure 3",
"      </a>",
"      ). Oocytes are then fertilized in-vitro by sperm provided by the recipient (ie, husband, partner, or sperm bank). In the case of \"shared egg donation,\" retrieved oocytes are usually divided equally among the parties in order to produce enough embryos for transfer (one to two embryos per transfer) to each of the recipients. The risk of complications (approximately 1 percent) in the donor is similar to that of infertile women who undergo the same procedure, and include anesthetic accidents, hemorrhage, infection, and development of the ovarian hyperstimulation syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/23\">",
"       23",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=see_link&amp;anchor=H22#H22\">",
"       \"Overview of ovulation induction\", section on 'Multiple gestation and ovarian hyperstimulation syndrome (OHSS)'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3520668\">",
"    <span class=\"h3\">",
"     Risks and complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women should be informed that there is a risk, albeit low, of potential complications when donating oocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective study of 587 donors undergoing 973 cycles of controlled ovarian hyperstimulation and 886 oocyte retrievals, the rate of serious complications (ovarian hyperstimulation syndrome [OHSS], ovarian torsion, infections, ruptured ovarian cyst) was 6 in 886 (0.7 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/24\">",
"       24",
"      </a>",
"      ]. The incidence of other complications serious enough to seek medical attention (mild to moderate OHSS, ovarian cysts, intraabdominal bleeding, ovarian cyst, hematoma) was 8.5 percent. The cycle cancellation rate was 9 percent.",
"     </li>",
"     <li>",
"      Similar rates and types of complications were seen in a second report of 1917 oocyte donors [",
"      <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H443959\">",
"    <span class=\"h2\">",
"     Recipient",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cycle of the recipient is synchronized with that of the donor by estrogen-progestin therapy, usually given as micronized estradiol orally and progesterone vaginally [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/26\">",
"     26",
"    </a>",
"    ]. Other formulations and routes of delivery include transdermal estradiol and intramuscular progesterone.",
"   </p>",
"   <p>",
"    An alternative approach is to give the recipient a fixed dose of micronized estradiol (2 to 6",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    to maintain a constant state of readiness for transfer [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/27\">",
"     27",
"    </a>",
"    ]. This approach has been popular in areas where donor availability is limited, or when the source of gametes depends upon the sporadic donation of oocytes from infertile women undergoing in vitro fertilization. Progesterone is added to the recipient's hormone regimen before embryo transfer either as an intramuscular injection or vaginal suppository.",
"   </p>",
"   <p>",
"    The approach is slightly different for women with primary ovarian insufficiency and those with regular ovulatory cycles:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For recipient women with primary ovarian insufficiency, endometrial preparation is achieved by prescribing estradiol followed by progesterone at an appropriate time to ensure endometrial receptivity is achieved when embryos are ready to be transferred.",
"     </li>",
"     <li>",
"      For recipient women with regular ovulatory cycles, a GnRH analog (agonist or antagonist) is used to suppress ovarian activity. The woman is then treated with sequential estradiol followed by progesterone to establish endometrial receptivity [",
"      <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A meta-analysis of 22 trials concluded that the different regimens for hormone replacement are associated with similar",
"    <strong>",
"     pregnancy",
"    </strong>",
"    rates [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/29\">",
"     29",
"    </a>",
"    ]. Minimal risks to the mother or child are posed by the use of any of these medications, and untoward side effects are rare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H444020\">",
"    <span class=\"h3\">",
"     Potential complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reported complications in recipients include a tuboovarian abscess after embryo transfer, ectopic pregnancies, chromosomal abnormalities in offspring, and third-trimester maternal deaths secondary to vascular accidents such as cerebral or aortic aneurysm rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. These complications are not unique to oocyte donation; they also occur in women undergoing in vitro fertilization as well as spontaneous pregnancies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H444086\">",
"    <span class=\"h3\">",
"     Disclosure",
"    </span>",
"    &nbsp;&mdash;&nbsp;There has been considerable controversy over whether offspring should be informed about the facts of their conception, with arguments for both disclosure and non-disclosure. The Ethics Committee of the American Society for Reproductive Medicine supports disclosure and has made policy suggestions for ART programs and sperm banks [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PREGNANCY AND OBSTETRICAL OUTCOMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H684709499\">",
"    <span class=\"h2\">",
"     Pregnancy rates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Considering the high rate of success of viable intrauterine pregnancy using oocyte donation, it is reasonable to assume that the majority of women will eventually deliver babies. Life-table analysis of 500 consecutive cycles of oocyte donation performed in the early 1990s demonstrated more than one-half of all the recipients achieved a viable pregnancy by the third embryo transfer regardless of age or diagnosis (",
"    <a class=\"graphic graphic_figure graphicRef59102 \" href=\"UTD.htm?43/37/44638\">",
"     figure 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef52891 \" href=\"UTD.htm?18/22/18788\">",
"     figure 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Today, with national birth rates at 50 to 60 percent per embryo transfer, it is reasonable to assume that success may be obtained in 75 to 90 percent of patients given similar opportunity for multiple attempts [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H684709506\">",
"    <span class=\"h2\">",
"     Pregnancy outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no unique problems associated with pregnancy after oocyte donation and the outcome is generally good. Nevertheless, most of the women are older than 35 years and should be considered to have high-risk pregnancies. In addition, multiple gestations are very common (over 40 percent of pregnancies), further complicating obstetric care. Therefore, it remains important to emphasize to all recipients, particularly women of advanced reproductive age (&gt;40 years), the value of a single embryo transfer in an effort to lower the risk of multiple gestation.",
"   </p>",
"   <p>",
"    Outcome continues to be relatively good in women over the age of 45. One study of 74 women aged 45 to 56 years, as an example, found the following [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/36\">",
"     36",
"    </a>",
"    ]:",
"    <br/>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Singleton births occurred in 45, twins in 24, and triplets in five.",
"     </li>",
"     <li>",
"      The average birth weight was 3218 g for the singletons, 2558 g for the twins, and 1775 g for the triplets.",
"     </li>",
"     <li>",
"      The average delivery time was at 38 weeks for the singletons, 36 weeks for the twins, and 34.5 weeks for the triplets.",
"     </li>",
"     <li>",
"      Antenatal complications occurred in 28 women (38 percent) and included preterm labor (n = 9), gestational hypertension (n = 8), gestational diabetes (n = 6), preterm rupture of membranes (n = 3), placenta previa (n = 3), placenta accreta (n = 2), preeclampsia (n = 2), HELLP syndrome (n = 2), and carpal tunnel syndrome (n = 2).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H684709563\">",
"    <span class=\"h3\">",
"     Gestational hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gestational hypertension occurs more frequently in women with donor oocyte pregnancies compared to IVF with autologous oocyte pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/37-42\">",
"     37-42",
"    </a>",
"    ]. It was initially thought that the older age of the women undergoing donor oocyte might explain some of the increase [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/37,40\">",
"     37,40",
"    </a>",
"    ]. However, in several studies of age-matched groups of pregnant women who had undergone IVF with either donor or autologous oocytes, an excess risk of gestational hypertension and preeclampsia was still observed [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/38,39,41,42\">",
"     38,39,41,42",
"    </a>",
"    ]. One possible mechanism for the increase in risk is that foreign antigens on trophoblastic tissue could trigger an autoimmune response in the mother. However, this has not yet been studied.",
"   </p>",
"   <p>",
"    Because of the advanced maternal age, high rate of multiple gestation, and risk of gestational hypertension, 50 to 70 percent of women are delivered by cesarean section [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/41,43\">",
"     41,43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ALTERNATIVE SOURCES OF DONOR OOCYTES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1991, pregnancy in a functionally agonadal woman was reported using immature oocytes obtained from surgically excised ovaries [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/44\">",
"     44",
"    </a>",
"    ]. Others have successfully retrieved oocytes from natural cycles, maturing and fertilizing the eggs in vitro using culture media enriched with follicular fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/45\">",
"     45",
"    </a>",
"    ]. Several pregnancies resulted using these oocytes donated from unstimulated ovaries. Although these are preliminary findings, avoiding the need for ovarian hyperstimulation would lessen both the risk and the cost of oocyte donation and would further improve safety.",
"   </p>",
"   <p>",
"    Other possibilities for increasing the donor pool have been investigated:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Live births in mice have occurred following the transplantation of cryopreserved autologous ovaries [",
"      <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The ability to retrieve immature oocytes from mouse embryos and culture them in vitro for purposes of oocyte donation to recipient animals has been demonstrated [",
"      <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/47\">",
"       47",
"      </a>",
"      ]. Oocytes procured from electively aborted fetuses could be similarly used as a source of donor eggs [",
"      <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cadaver ovaries donated for medical use, similar to other organ grafts, have also been suggested as a source [",
"      <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The use of either fetal oocytes or cadaver ovaries raises important ethical issues, which would need to be resolved before considering such an approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Cryopreservation of oocytes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vast improvements in cryopreservation of oocytes have occurred in recent years, which make possible the banking of eggs. Successful oocyte freezing and thawing might simplify the current approach to egg donation using freshly harvested gametes since it would obviate the need for synchronization of recipients, which can be a timely and costly process. Furthermore, meeting FDA requirements for the testing of donors within the 30 day window prior to egg retrieval would be easier to manage if donors did not need to be synchronized to the recipients. Finally, reducing the cryopreservation of large numbers of supernumerary embryos produced through conventional IVF methodology would lessen ethical concerns over the disposition of unused embryos that often result from donor egg cycles. This approach has demonstrated preliminary success in several series reports [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24807/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H584065203\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oocyte (egg) donation is an important part of modern assisted reproductive care. Originally offered only to women with primary ovarian insufficiency (premature ovarian failure) or those who had genetic diseases who did not want to transmit the gene defect to their offspring, donated oocytes are now also used for women with a variety of reproductive disorders as well as for postmenopausal women. Approximately 17,000 attempts at pregnancy using in vitro fertilization (IVF) with donated oocytes are initiated annually in the United States.",
"   </p>",
"   <p>",
"    Indications for undergoing IVF with donor oocytes include (see",
"    <a class=\"local\" href=\"#H4\">",
"     'Indications'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary ovarian insufficiency (premature ovarian failure) or gonadal dysgenesis",
"     </li>",
"     <li>",
"      Avoidance of genetic disease transmission",
"     </li>",
"     <li>",
"      Declining or absent ovarian function",
"     </li>",
"     <li>",
"      Persistent poor oocyte quality during assisted reproductive technologies",
"     </li>",
"     <li>",
"      Advanced reproductive age (&gt;40 years)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Oocyte donation is typically accomplished by synchronizing the menstrual cycle of the recipient with a hyperstimulated cycle of the woman who is donating her oocytes (",
"    <a class=\"graphic graphic_figure graphicRef75520 \" href=\"UTD.htm?27/35/28210\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H584065701\">",
"     'Current approach'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Conception rates are high with this technology, and pregnancy outcomes are good. Rates of gestational hypertension are higher in women undergoing IVF with donor oocytes when compared to those using autologous oocytes. The mechanism for this difference is unknown. (See",
"    <a class=\"local\" href=\"#H684709506\">",
"     'Pregnancy outcome'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H684709563\">",
"     'Gestational hypertension'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/1\">",
"      Sauer MV, Kavic SM. Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy. Reprod Biomed Online 2006; 12:153.",
"     </a>",
"    </li>",
"    <li>",
"     2006 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports. Centers for Disease Control (CDC) and American Society for Reproductive Medicine (ASRM). United States Department of Health and Human Services, November 2008. p. 89.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/3\">",
"      Betteridge KJ, Rieger D. Embryo transfer and related techniques in domestic animals, and their implications for human medicine. Hum Reprod 1993; 8:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/4\">",
"      Trounson A, Leeton J, Besanko M, et al. Pregnancy established in an infertile patient after transfer of a donated embryo fertilised in vitro. Br Med J (Clin Res Ed) 1983; 286:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/5\">",
"      Buster JE, Bustillo M, Thorneycroft IH, et al. Non-surgical transfer of in vivo fertilised donated ova to five infertile women: report of two pregnancies. Lancet 1983; 2:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/6\">",
"      Lutjen P, Trounson A, Leeton J, et al. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature 1984; 307:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/7\">",
"      Sauer MV, Bustillo M, Gorrill MJ, et al. An instrument for the recovery of preimplantation uterine ova. Obstet Gynecol 1988; 71:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/8\">",
"      Sauer MV, Paulson RJ. Human oocyte and preembryo donation: an evolving method for the treatment of infertility. Am J Obstet Gynecol 1990; 163:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/9\">",
"      Borrero C, Remohi J, Ord T, et al. A program of oocyte donation and gamete intra-fallopian transfer. Hum Reprod 1989; 4:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/10\">",
"      Balmaceda JP, Alam V, Roszjtein D, et al. Embryo implantation rates in oocyte donation: a prospective comparison of tubal versus uterine transfers. Fertil Steril 1992; 57:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/11\">",
"      Serhal PF, Craft IL. Oocyte donation in 61 patients. Lancet 1989; 1:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/12\">",
"      Sauer MV, Paulson RJ, Lobo RA. A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med 1990; 323:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/13\">",
"      Sauer MV, Paulson RJ, Lobo RA. Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA 1992; 268:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/14\">",
"      Practice Committee of the American Society for Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril 2006; 86:S127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/15\">",
"      Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the Society for Assisted Reproductive Technology. Guidelines on number of embryos transferred. Fertil Steril 2009; 92:1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/16\">",
"      Rieger D. Gamete donation: an opinion on the recommendations of the Royal Commission on New Reproductive Technologies. CMAJ 1994; 151:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/17\">",
"      Sauer MV, Paulson RJ. Oocyte donors: a demographic analysis of women at the University of Southern California. Hum Reprod 1992; 7:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/18\">",
"      Sauer MV, Paulson RJ, Lobo RA. Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation. Fertil Steril 1995; 64:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/19\">",
"      Mechanick Braverman A. Survey results on the current practice of ovum donation. Ovum Donor Task Force of the Psychological Special Interests Group of the American Fertility Society. Fertil Steril 1993; 59:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/20\">",
"      de Ziegler D, Frydman R. Different implantation rates after transfers of cryopreserved embryos originating from donated oocytes or from regular in vitro fertilization. Fertil Steril 1990; 54:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/21\">",
"      The American Fertility Society (Sauer, MV, Schmidt-Sarosi, CL, Quigley, MM). Guidelines for oocyte donation. Fertil Steril 1993; 59:5S.",
"     </a>",
"    </li>",
"    <li>",
"     Center for Devices and Radiological Health (CDRH), U.S. Food and Drug Administration. Title 21-Food and Drugs. Chapter I: Food and Drug Administration, Department of Health and Human Services. Subchapter L: Regulations under Certain Other Acts Administered by the Food and Drug Administration. Part 1271: Human Cells, Tissues, and Cellular and Tissue-Based Products.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/23\">",
"      Sauer MV. Defining the incidence of serious complications experienced by oocyte donors: a review of 1000 cases. Am J Obstet Gynecol 2001; 184:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/24\">",
"      Maxwell KN, Cholst IN, Rosenwaks Z. The incidence of both serious and minor complications in young women undergoing oocyte donation. Fertil Steril 2008; 90:2165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/25\">",
"      Bodri D, Guill&eacute;n JJ, Polo A, et al. Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles. Reprod Biomed Online 2008; 17:237.",
"     </a>",
"    </li>",
"    <li>",
"     Sauer MV, Cohen MA. Egg and Embryo Donation. In: Textbook of Assisted Reproductive Technologies, 2nd, Gardner DK (Ed), Taylor &amp; Francis, London 2004. p.843.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/27\">",
"      Younis JS, Simon A, Laufer N. Endometrial preparation: lessons from oocyte donation. Fertil Steril 1996; 66:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/28\">",
"      Devroey P, Pados G. Preparation of endometrium for egg donation. Hum Reprod Update 1998; 4:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/29\">",
"      Glujovsky D, Pesce R, Fiszbajn G, et al. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database Syst Rev 2010; :CD006359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/30\">",
"      Sauer MV, Paulson RJ. Pelvic abscess complicating transcervical embryo transfer. Am J Obstet Gynecol 1992; 166:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/31\">",
"      Bewley S, Wright JT. Maternal death associated with ovum donation twin pregnancy. Hum Reprod 1991; 6:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/32\">",
"      Karnis MF, Zimon AE, Lalwani SI, et al. Risk of death in pregnancy achieved through oocyte donation in patients with Turner syndrome: a national survey. Fertil Steril 2003; 80:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/33\">",
"      Ethics Committee of the American Society for Reproductive Medicine. Informing offspring of their conception by gamete donation. Fertil Steril 2004; 81:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/34\">",
"      Paulson RJ, Hatch IE, Lobo RA, Sauer MV. Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum Reprod 1997; 12:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/35\">",
"      Ameratunga D, Weston G, Osianlis T, et al. In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure (POF) compared with women with physiological age-related menopause? J Assist Reprod Genet 2009; 26:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/36\">",
"      Sauer MV, Paulson RJ, Lobo RA. Oocyte donation to women of advanced reproductive age: pregnancy results and obstetrical outcomes in patients 45 years and older. Hum Reprod 1996; 11:2540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/37\">",
"      Porreco RP, Harden L, Gambotto M, Shapiro H. Expectation of pregnancy outcome among mature women. Am J Obstet Gynecol 2005; 192:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/38\">",
"      Wiggins DA, Main E. Outcomes of pregnancies achieved by donor egg in vitro fertilization--a comparison with standard in vitro fertilization pregnancies. Am J Obstet Gynecol 2005; 192:2002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/39\">",
"      Krieg SA, Henne MB, Westphal LM. Obstetric outcomes in donor oocyte pregnancies compared with advanced maternal age in in vitro fertilization pregnancies. Fertil Steril 2008; 90:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/40\">",
"      Henne MB, Zhang M, Paroski S, et al. Comparison of obstetric outcomes in recipients of donor oocytes vs. women of advanced maternal age with autologous oocytes. J Reprod Med 2007; 52:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/41\">",
"      Keegan DA, Krey LC, Chang HC, Noyes N. Increased risk of pregnancy-induced hypertension in young recipients of donated oocytes. Fertil Steril 2007; 87:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/42\">",
"      Klatsky PC, Delaney SS, Caughey AB, et al. The role of embryonic origin in preeclampsia: a comparison of autologous in vitro fertilization and ovum donor pregnancies. Obstet Gynecol 2010; 116:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/43\">",
"      Pados G, Camus M, Van Steirteghem A, et al. The evolution and outcome of pregnancies from oocyte donation. Hum Reprod 1994; 9:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/44\">",
"      Cha KY, Koo JJ, Ko JJ, et al. Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril 1991; 55:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/45\">",
"      Russell, JB, Knezevich, KM, Fabian, K, et al. In vitro oocyte maturation: Clinical applicability (abstract). Fertil Steril 1996; (Suppl):S22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/46\">",
"      Gunasena KT, Villines PM, Critser ES, Critser JK. Live births after autologous transplant of cryopreserved mouse ovaries. Hum Reprod 1997; 12:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/47\">",
"      Gosden RG. Transplantation of fetal germ cells. J Assist Reprod Genet 1992; 9:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/48\">",
"      Edwards JH, Benham JD. Views on donated ovarian tissue. Lancet 1994; 344:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/49\">",
"      Seibel MM. Cadaveric ovary donation. N Engl J Med 1994; 330:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/50\">",
"      Nagy ZP, Chang CC, Shapiro DB, et al. Clinical evaluation of the efficiency of an oocyte donation program using egg cryo-banking. Fertil Steril 2009; 92:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24807/abstract/51\">",
"      Cobo A, Remoh&iacute; J, Chang CC, Nagy ZP. Oocyte cryopreservation for donor egg banking. Reprod Biomed Online 2011; 23:341.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7405 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-CDD449C725-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24807=[""].join("\n");
var outline_f24_14_24807=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H584065203\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORICAL MILESTONES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H684709401\">",
"      Special considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H684709409\">",
"      - Turner syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H684709472\">",
"      - Advanced reproductive age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DONOR SELECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H584065701\">",
"      CURRENT APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H443952\">",
"      Donor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3520646\">",
"      - Protocol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3520668\">",
"      - Risks and complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H443959\">",
"      Recipient",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H444020\">",
"      - Potential complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H444086\">",
"      - Disclosure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PREGNANCY AND OBSTETRICAL OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H684709499\">",
"      Pregnancy rates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H684709506\">",
"      Pregnancy outcome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H684709563\">",
"      - Gestational hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ALTERNATIVE SOURCES OF DONOR OOCYTES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Cryopreservation of oocytes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H584065203\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7405\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7405|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/14/24814\" title=\"figure 1\">",
"      Percentage of donor oocyte",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/35/28210\" title=\"figure 2\">",
"      Egg donor synchronization schedule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/37/44638\" title=\"figure 4\">",
"      Pregnancy rate by age of donor oocyte",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/22/18788\" title=\"figure 5\">",
"      Delivery rates by diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7405|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/23/11647\" title=\"figure 3\">",
"      Technique for oocyte recovery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37770?source=related_link\">",
"      In vitro fertilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/63/14329?source=related_link\">",
"      Management of Turner syndrome (gonadal dysgenesis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=related_link\">",
"      Overview of ovulation induction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22647?source=related_link\">",
"      Prevention of ovarian hyperstimulation syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_14_24808="Colposcopy";
var content_f24_14_24808=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Colposcopy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/14/24808/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/14/24808/contributors\">",
"     Colleen M Feltmate, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/14/24808/contributors\">",
"     Sarah Feldman, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/14/24808/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/14/24808/contributors\">",
"     Barbara Goff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/14/24808/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/14/24808/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/14/24808/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colposcopy is a diagnostic procedure in which a colposcope (a dissecting microscope with various magnification lenses) is used to provide an illuminated, magnified view of the cervix, vagina, and vulva (",
"    <a class=\"graphic graphic_picture graphicRef80392 \" href=\"UTD.htm?7/42/7854\">",
"     picture 1",
"    </a>",
"    ). Colposcopic evaluation of the cervix and vagina is based on the finding that malignant and premalignant epithelium have specific macroscopic characteristics relating to contour, color, and vascular pattern that are recognizable by colposcopy. The improved visualization of epithelial surfaces enhances the colposcopist's ability to distinguish normal from abnormal areas and to obtain directed biopsies from suspicious tissue. Colposcopy of the vulva, a keratinized epithelium, provides a magnified bright light examination. The primary goal of colposcopy is to identify precancerous and cancerous lesions so that they may be treated early.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2006, the American Society for Colposcopy and Cervical Pathology (ASCCP) convened a conference to create guidelines for management of women with abnormal cervical cancer screening tests and cervical intraepithelial neoplasia based on the best available evidence [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Multiple organizations committed to women's health and cancer care were represented at the conference. Colposcopy was recommended for the following general categories in adult women; (the recommendations were modified for adolescents):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Specific cytological abnormalities:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Persistent atypical cells of undetermined significance (ASC-US) or ASC-US with positive high-risk human papillomavirus (HPV) subtypes",
"     </li>",
"     <li>",
"      ASC suggestive of high-grade lesion (ASC-H)",
"     </li>",
"     <li>",
"      Atypical glandular cells (AGC)",
"     </li>",
"     <li>",
"      Low-grade squamous intraepithelial lesions (LSIL)",
"     </li>",
"     <li>",
"      High-grade squamous intraepithelial lesion (HSIL)",
"     </li>",
"     <li>",
"      Suspicious for invasive cancer",
"     </li>",
"     <li>",
"      Malignant cells present",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These cytologic abnormalities and their management are described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/15/40185?source=see_link\">",
"     \"Cervical cytology: Interpretation of results\"",
"    </a>",
"    .) (See also individual topic reviews for each lesion).",
"   </p>",
"   <p>",
"    Additional common indications for colposcopy include [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation of patients with persistent (two consecutive years) positive testing for high-risk human papillomavirus and normal cytology. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/16/38154?source=see_link&amp;anchor=H8372719#H8372719\">",
"       \"Screening for cervical cancer: Rationale and recommendations\", section on 'Normal Pap smear and positive HPV test'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Assessment of women exposed to diethylstilbestrol (DES) exposure in utero. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3322?source=see_link\">",
"       \"Outcome and follow-up of diethylstilbestrol (DES) exposed individuals\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evaluation of a palpably or visually abnormal cervix, vagina, or vulva (see individual topic reviews).",
"     </li>",
"     <li>",
"      In conjunction with laser or other treatment modalities to ensure that known lesions are completely removed or treated, to detect any other lesions in surrounding areas, and for posttreatment surveillance.&nbsp;(See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/2/30762?source=see_link\">",
"       \"Cervical intraepithelial neoplasia: Management\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evaluation of a positive screening test for cervical neoplasia such as spectroscopy, cervicography, or speculoscopy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no absolute contraindications to colposcopy. Active cervicitis is treated before the examination because inflammation and infection impede accurate assessment of epithelial abnormalities. Trichomonas vaginalis can cause cervicitis, but vaginal infections do not affect colposcopy. However, treatment before colposcopy may allow the patient to be more comfortable during the examination. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/4/64?source=see_link\">",
"     \"Acute cervicitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=see_link\">",
"     \"Approach to women with symptoms of vaginitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     COLPOSCOPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initially, a complete medical history is obtained. Specific items that can be important for interpreting cytology, histology, and colposcopy findings include pregnancy history, last menstrual period, use of any type of hormones or hormonal contraception, prior cervical cytology results, results of human papillomavirus testing, allergies, medications, HIV status, immunosuppressive conditions, and prior cervical procedures. Iodine allergy is not uncommon; this history should be obtained prior to the procedure so that iodine containing solutions, which are commonly utilized during the examination, can be avoided in these women.",
"   </p>",
"   <p>",
"    If there is any possibility of pregnancy, a pregnancy test should be obtained as endocervical curettage is",
"    <strong>",
"     NOT",
"    </strong>",
"    performed in pregnant women because of potential trauma to the gestational sac and heavy bleeding.",
"   </p>",
"   <p>",
"    If the patient's cervical cytology was read at an outside laboratory or by an unfamiliar cytologist, we often obtain a second review of the slides to confirm the cytologic diagnosis.",
"   </p>",
"   <p>",
"    The procedure is explained to the patient, her questions are answered, and she may be asked to sign a consent form (",
"    <a class=\"graphic graphic_form graphicRef69421 \" href=\"UTD.htm?42/21/43345\">",
"     form 1",
"    </a>",
"    ). Provision of written and video information at the precolposcopy sessions and allowing the patient to watch her procedure by video can improve compliance to follow-up after colposcopy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Anxiety appears to be reduced by playing music during colposcopy, showing informational videos prior to colposcopy, and viewing video colposcopy during the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/5\">",
"     5",
"    </a>",
"    ]. Although printed information leaflets did not reduce anxiety levels, they did increase knowledge levels.",
"   </p>",
"   <p>",
"    Prior to starting the examination, all necessary equipment and supplies should be readily available to the colposcopist (",
"    <a class=\"graphic graphic_table graphicRef60238 \" href=\"UTD.htm?40/52/41804\">",
"     table 1",
"    </a>",
"    ) and an assistant should be present throughout the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Colposcope",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intraocular distance on the colposcope should be adjusted prior to starting the procedure to ensure binocular vision. Most colposcopes have a focal length (ie, working distance between the lens and target tissue) of 30 cm. If the focal length is too short or long, the colposcopist will not have the appropriate amount of room to maneuver instruments. Colposcopes differ by manufacturer and magnification can range from 7.5 to 30. By moving the head of the colposcope closer and farther from the patient, the focus, and sometimes the magnification, changes, depending on the type of colposcope. As an example, one type of video colposcope automatically adjusts the magnification, depending on how close the scope is to the patient, and this is based on the focus. Fine focusing can be done by turning a knob; coarse focusing is performed by moving the instrument toward or away from the patient.",
"   </p>",
"   <p>",
"    The colposcope functions as a lighted binocular microscope, which magnifies the tissue of interest (eg, cervical, vaginal, or vulvar epithelium), thereby helping to identify features suggestive of abnormal tissue. Low power (2x to 10x) is often used to obtain an overall impression of surface architecture and for examination of the vulva. Medium (10x to 20x) and high (20x to 25x) powers are utilized to evaluate the vagina and cervix, with high power being particularly useful for close inspection of vascular patterns, which can signify high-grade or invasive disease. A consistent plan for magnification (usually starting at 15x) is important so that examinations are comparable and reproducible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colposcopy is performed with the patient in the dorsal lithotomy position. After visually examining the vulva and determining if there are any suspicious areas, a speculum is placed in the vagina. It is best to use the largest speculum possible so that the entire cervix and vaginal fornices may be visualized.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Repeat cervical cytology",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the patient has not had cervical cytology in the past six weeks, a repeat assessment of cervical cytology is done because up to 50 to 60 percent of LSIL and 30 percent of HSIL resolve over time. A recent cytological result enables the colposcopist to make the most accurate correlation of cytologic, colposcopic, and histologic findings. Performing cervical cytology at less than a six week interval, however, may lead to a false negative result since it may take up to six weeks for cervical epithelium to regenerate after being sampled. If indicated, HPV testing can be done on the cytology specimen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cervix and vagina are examined with a bright light, and then with the colposcope. Cotton soaked in saline may be used to cleanse a cervix that is covered with mucus, blood, discharge, or debris, to facilitate viewing. The cervix is first viewed before application of additional solutions, to look for areas of erosion, true leukoplakia, pigmented lesions, or areas of obvious ulceration or exophytic growth.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19011?source=see_link\">",
"     Acetic acid",
"    </a>",
"    solution is used to improve visualization of abnormal areas. Three to 5 percent acetic acid is applied to the cervix using cotton swabs to enhance definition of the squamocolumnar junction. After 30 to 60 seconds, the acidic solution dehydrates cells so that squamous cells with relatively large or dense nuclei (eg, metaplastic cells, dysplastic cells, cells infected with human papilloma virus) reflect light and thus appear white. Blood vessels and columnar cells are not affected, but become easier to visualize against the white background. The acetic acid should be reapplied, as needed, after three to five minutes. If excessive acetic acid pools in the vagina, it should be removed with dry swabs, as it can cause irritation.",
"   </p>",
"   <p>",
"    When dealing with a hypertrophied cervix, or markedly redundant vagina, it is sometimes necessary to attach a tenaculum to the cervix to allow manipulation and visualization of the entire cervix.",
"   </p>",
"   <p>",
"    The clinician first identifies the squamocolumnar junction or transformation (TZ) zone. The differential absorption of light between squamous epithelial cells and columnar cells allows the clinician to differentiate between the smooth grey-pink appearing ectocervix and the pink-red cobblestone appearing endocervix. The region where the two cell types meet, termed the squamocolumnar junction, defines the \"transformation\" zone (",
"    <a class=\"graphic graphic_picture graphicRef64778 \" href=\"UTD.htm?22/51/23344\">",
"     picture 2",
"    </a>",
"    ) where the columnar cells become squamoid. The transformation zone represents the region of active cell division and therefore it is the region most likely to display abnormal growth. It is the area between an older squamocolumnar junction and the current one. The location of this region is altered by age, hormonal conditions such as menopause, hormonal contraception and pregnancy, prior cervical treatments and vaginal pH. The ability to see the transformation zone dictates whether the colposcopic examination is adequate (ie, the entire squamocolumnar junction is visible circumferentially around the os) or unsatisfactory. In addition, the margins of any visible lesions must be fully identified for an adequate examination. Areas of abnormal contour (eg, erosion) or areas where the epithelium is heaped upon itself, are also noted.",
"   </p>",
"   <p>",
"    Areas of acetowhite epithelium [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/6\">",
"     6",
"    </a>",
"    ] and abnormal vascular patterns are noted and documented. An endocervical speculum can assist in delineating the squamocolumnar junction or the upper margin of a lesion or a wet Q-tip may be used; the Q-tip is often less traumatic. Acetowhite lesions with sharp borders are more likely to be significant lesions, while diffuse borders suggest low-grade disease.",
"   </p>",
"   <p>",
"    Areas of white epithelium are further evaluated for abnormal vascular patterns such as punctation, mosaicism, or abnormal appearing vessels. A green-filter examination is performed to accentuate abnormal vasculature. Use of a green or blue filter darkens blood vessels and sharpens the contrast between vessels and the surrounding epithelium. Punctate and mosaic vessels in a field of acetowhite epithelium in the transformation zone are suggestive of CIN, low (",
"    <a class=\"graphic graphic_picture graphicRef62988 \" href=\"UTD.htm?5/47/5872\">",
"     picture 3",
"    </a>",
"    ) or high-grade (",
"    <a class=\"graphic graphic_picture graphicRef51434 \" href=\"UTD.htm?17/39/18032\">",
"     picture 4",
"    </a>",
"    ). Atypical vessels that have increased caliber (coarseness), display irregular and abrupt changes in direction, are widely spaced, suddenly terminate, or have corkscrew, comma, or hairpin patterns are suggestive of microinvasive or invasive disease. Although these visual changes are helpful for directing biopsies, an accurate diagnosis can only be established definitively by pathologic examination of the biopsied tissue. Various systems have been proposed to describe abnormal colposcopic findings and categorize these findings in terms of their ability to predict the degree of histologic abnormality, but these have not proven to be reliable [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/7\">",
"     7",
"    </a>",
"    ]. However, no colposcopic findings are pathognomonic of malignancy.",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     Ulcerations/erosions",
"    </span>",
"    may also be seen and can be due to trauma, infection, or neoplasms. Similarly, heaped up epithelium may represent mitotically active tissue, such as neoplasm or condylomata.",
"   </p>",
"   <p>",
"    The upper one-third of the vagina, in particular the lateral fornices, is also inspected. The transformation zone and squamocolumnar junction may extend into the upper vagina, particularly in younger patients. Abnormal vaginal findings include adenosis, polyps, cysts, DES morphology, condyloma, and changes suggestive of preinvasive or invasive disease.",
"   </p>",
"   <p>",
"    If no lesions are seen, a dilute Lugol's or Schiller's solution may be applied to the cervix and vagina to aid in detection. Lugol's iodine consists of 5 g of iodine and 10 g of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/27/30134?source=see_link\">",
"     potassium iodide",
"    </a>",
"    in 100 mL distilled water [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/8\">",
"     8",
"    </a>",
"    ]. Uniform uptake of stain would confirm the colposcopist's impression that no lesion is present. Glycogen containing cells will take up iodine and become dark brown. Nonglycogenated cells, such as normal columnar or glandular cells, high-grade lesions, and many low-grade lesions, will not take up iodine and remain light yellow. Thus, they can be easily differentiated from normal tissue for sampling or treatment purposes. Iodine staining should not reveal any lesions the examiner has not previously identified with saline or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19011?source=see_link\">",
"     acetic acid",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Biopsies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The colposcopist should be able to differentiate between minimally abnormal and significantly abnormal findings. Traditionally, only a single biopsy was obtained from the most abnormal appearing area using long biopsy instruments. However, detection of CIN is enhanced by obtaining multiple biopsies, such as from another part of the most abnormal appearing area or from more than one abnormal appearing area (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Effectiveness'",
"    </a>",
"    below). In a prospective study, biopsy of multiple versus single sites was not associated with an increased likelihood of acquiring new HPV infections [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/9\">",
"     9",
"    </a>",
"    ]. Biopsies should be taken from inferior to superior to avoid bleeding over the target sites. Each specimen is individually labeled according to its location on the cervix (as if taken from the face of a clock) and placed in a separate, labeled container containing a permanent fixative. A comparison of normal, low-grade, and high-grade lesions by cervical cytology and histology is shown in the figure (",
"    <a class=\"graphic graphic_figure graphicRef60116 \" href=\"UTD.htm?4/20/4423\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Local anesthesia is not routinely used for biopsies of the cervix and upper vagina, since injection of the anesthetic is probably as painful as the biopsy. Distraction techniques (eg, asking the patient to cough at the time of biopsy) are as effective as local anesthetic injection and require less time [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/10\">",
"     10",
"    </a>",
"    ]. Topical and oral analgesics are ineffective [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Biopsies are relatively contraindicated in patients on anticoagulants, who have a known bleeding disorder, or who are pregnant because of the increased risk of bleeding in these settings. If a biopsy is necessary, appropriate steps should be taken to minimize bleeding and to treat heavy bleeding if it occurs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Endocervical curettage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endocervical curettage (ECC) or sampling is indicated in patients with ASC-H; HSIL; AGC; adenocarcinoma in situ (AIS);",
"    <span class=\"nowrap\">",
"     ASC-US/LSIL",
"    </span>",
"    but no visible lesion, especially if ablative treatment is contemplated; and those with an unsatisfactory colposcopic examination. Some colposcopists perform ECC as part of all colposcopic examinations on non-pregnant patients because of data suggesting it increases the sensitivity of the examination, especially in older women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A long straight curette is used to scrape the four quadrants of the endocervical canal and an endocervical brush is employed to remove any exfoliated tissue. These specimens are deposited in a jar containing permanent fixative and labeled 'endocervical curettage'. A drop of mucus and blood is often seen at the os after ECC, and this should be included in the specimen. Endocervical curettage is",
"    <strong>",
"     NOT",
"    </strong>",
"    performed in pregnant women.",
"   </p>",
"   <p>",
"    ECC samples may be contaminated by cells from the cervical portio. However, any",
"    <span class=\"nowrap\">",
"     neoplastic/dysplastic",
"    </span>",
"    epithelium constitute a \"positive\" endocervical curettage. The clinician must determine, based upon the colposcopic examination, whether the abnormal epithelium was more or less likely to be a contaminant from the portio. In particular, a positive ECC in a postmenopausal woman or one in which the squamo-columnar junction could not be visualized would generate the greatest concern for canal involvement.",
"   </p>",
"   <p>",
"    An endocervical curettage that does not show endocervical tissue is an inadequate result and cannot be construed as a negative result. In such cases, repeat sampling should be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Documentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colposcopic examinations should be documented in a consistent and reproducible way. The format of documentation will vary by practice of institution, depending on whether paper or electronic medical records are used.",
"   </p>",
"   <p>",
"    An example of a paper form is shown in the figure (",
"    <a class=\"graphic graphic_form graphicRef67886 \" href=\"UTD.htm?12/63/13311\">",
"     form 2",
"    </a>",
"    ). Abbreviations are noted on the diagram to help with documenting findings. Frequently used terms include: transformation zone (TZ), white epithelium (WE), leukoplakia (L), squamous metaplasia (SM), ectopy (E), punctation (P), mosaicism (M), atypical vessels (AV), adenosis (AS), and Nabothian cyst (NC). As discussed above, biopsies should be numbered as if on the face of a clock and indicated on the diagram and separately on the pathology requisition. The adequacy of the examination and whether or not the vulva and vagina were specifically examined should be noted.",
"   </p>",
"   <p>",
"    New colposcopic terminology was published by the International Federation for Cervical Pathology and Colposcopy (IFCPC) in 2011 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/14\">",
"     14",
"    </a>",
"    ].&nbsp;The terminology refers to both cervical and vaginal colposcopic findings. For cervical colposcopy, three variables should be commented upon:&nbsp;1) adequate or inadequate, with a reason given; 2) visibility of the transformation zone (TZ), yes or no; and 3) transformation zone type (",
"    <a class=\"graphic graphic_table graphicRef86246 \" href=\"UTD.htm?29/5/29788\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Video and digital technology is available to take actual photographs or videos of the cervix in real-time. This technology is particularly useful in educational settings. A disadvantage of their use is medicolegal issues as future retrospective review of images may identify areas of abnormality which were initially \"missed.\" An advantage, however, is that the images may be stored electronically as part of the medical record, so that changes may be followed over time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications include bleeding, infection at the biopsy site or endometrium, and failure to identify the lesion. Significant bleeding and infection are rare.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/18/19747?source=see_link\">",
"     Ferric subsulfate",
"    </a>",
"    (Monsel's solution) is applied with either small or large cotton swabs to the biopsied areas to control bleeding. If necessary, sustained pressure with a cotton swab, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/53/42834?source=see_link\">",
"     silver nitrate",
"    </a>",
"    sticks, can also be used. Ferric subsulfate solution and silver nitrate interfere with interpretation of biopsy specimen, so these substances should not be applied until all biopsies have been taken.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Follow-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;We ask patients to avoid coitus for several days after biopsies are taken to minimize trauma to the cervix, which may result in bleeding. Patients should be given both verbal and written instructions as to how and when they will receive their results.",
"   </p>",
"   <p>",
"    The provider should review the cytology and histology results and",
"    <span class=\"nowrap\">",
"     his/her",
"    </span>",
"    colposcopic findings with consideration of the patient's age, medical conditions, and prior cervical cytology history before establishing a diagnosis and management plan.",
"   </p>",
"   <p>",
"    A single colposcopy has a significant chance of missing a high-grade abnormality (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Effectiveness'",
"    </a>",
"    below). For this reason, women with persistent abnormality on cytology or by HPV testing should undergo follow-up colposcopy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/15\">",
"     15",
"    </a>",
"    ]. Management recommendations are discussed separately [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/15/40185?source=see_link\">",
"     \"Cervical cytology: Interpretation of results\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/2/30762?source=see_link\">",
"     \"Cervical intraepithelial neoplasia: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     EFFECTIVENESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colposcopy is a diagnostic test for women with abnormal cervical cytologic results, it has not been found to be an effective screening tool when used alone [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of colposcopy depends upon the experience and training of the colposcopist. The final histologic diagnosis depends upon the ability of the colposcopist to interpret the colposcopic findings and obtain properly directed biopsies. Among experienced colposcopists, there is good interobserver agreement for normal epithelium, HSIL, and invasive cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/17\">",
"     17",
"    </a>",
"    ]. There is more interobserver variation in diagnosis of lower-grade abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/18\">",
"     18",
"    </a>",
"    ]; however, this lack of agreement is also true for histopathological diagnosis of these entities. The IFCPC has proposed features potentially associated with histologic diagnosis.&nbsp;The following criteria may assist the colposcopist categorizing the likelihood of lower versus higher-grade lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/19\">",
"     19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Features suggestive of metaplastic change or low-grade disease &ndash; Flat acetowhite epithelium, fine punctuation, fine mosaic or partial iodine positivity",
"     </li>",
"     <li>",
"      Features suggestive of high-grade disease &ndash; Dense acetowhite epithelium, coarse punctuation, coarse mosaic, atypical vessels, or iodine negativity;",
"     </li>",
"     <li>",
"      Features suggestive of invasive cancer &ndash; Erosion, dense acetowhite epithelium, coarse punctuation, coarse mosaic or atypical vessels.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnostic performance of colposcopy for detection of cervical neoplasia was evaluated in a meta-analysis of 32 studies including almost 8000 biopsies; excisional biopsy (cone biopsy, loop electrosurgical excision procedure) was the reference standard. To detect CIN2 or higher in the excisional biopsy, a colposcopic punch biopsy of CIN1 or higher had a sensitivity of 91 percent and a specificity of 25 percent and a punch biopsy result of CIN2 or higher had a sensitivity 80 percent and a specificity of 63 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Colposcopy using the 2011 International Federation of Cervical Pathology and Colposcopy classification was able to distinguish normal",
"    <span class=\"nowrap\">",
"     cervix/low-grade",
"    </span>",
"    lesions (CIN1) from high-grade lesions",
"    <span class=\"nowrap\">",
"     (CIN2/3)/carcinoma",
"    </span>",
"    with sensitivity of 61 percent and specificity of 94 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/14\">",
"     14",
"    </a>",
"    ]. One explanation for limitations of the sensitivity of colposcopy is that acetowhite epithelium is most often observed anteriorly and posteriorly, even in the absence of CIN; however, CIN may be similarly distributed in all four quadrants [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Performing two or more biopsies appears to increase sensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/12,22\">",
"     12,22",
"    </a>",
"    ]. Options include performing additional biopsies from another part of the most abnormal appearing lesion, from more than one abnormal appearing area, or randomly from normal appearing quadrants [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/22\">",
"     22",
"    </a>",
"    ]. The best approach has not been studied, but at this time random biopsies from normal appearing cervix are not recommended since this would lead to biopsy of very large numbers of women without disease and in the absence of information about cost- and risk-benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Colposcopy by an experienced colposcopist will usually detect patients with significant disease (HSIL, cancer), but some women with a normal colposcopic examination can still have a significant histologic abnormality. For this reason, it is important to reconcile the cytologic, colposcopic, and histologic findings in formulating a diagnosis and management plan for each woman. As discussed above, an adequate colposcopy requires that the entire squamocolumnar junction and all lesions be completely visualized and that biopsies of the lesions explain the abnormal cytology.",
"   </p>",
"   <p>",
"    If a patient is referred from another institution and the results of colposcopic biopsy do not correspond with previous results, the referral slides should be reviewed by the current institution.",
"   </p>",
"   <p>",
"    In women with cytology that is either suggestive of possible malignancy or shows frankly malignant cells, the colposcopic exam will not be considered adequate unless a biopsy is done which confirms the presence of cancer. In this situation, if invasive disease is not found, and a lesser lesion such as CIN 3 is detected, repeat colposcopy by a more experienced colposcopist and review of the referring cytology slide is appropriate before considering more invasive intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     VAGINAL COLPOSCOPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colposcopy of the vagina is very similar to that of the cervix, but the natural rugae and folds make the procedure more time consuming and difficult. A systematic approach, beginning in one quadrant and gradually working to cover all four quadrants, involves applying",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19011?source=see_link\">",
"     acetic acid",
"    </a>",
"    repeatedly, and noting areas of abnormal staining. Adenosis, pigmented lesions, and cysts are usually seen without the need of special stains. It is necessary to rotate the speculum to allow the anterior and posterior vagina to be visualized. Lugol's staining is helpful in delineating lesions, and in insuring that all abnormal areas have been identified.",
"   </p>",
"   <p>",
"    Opening the speculum as much as is feasible \"smoothes\" the vagina and facilitates colposcopy; however, when biopsy is attempted, it is helpful to partially close the speculum to allow the vagina to fold in on itself. Keeping the vagina taut makes biopsy difficult. Cysts and adenosis are usually easy to sample. The site of the lesion is documented using the vaginal apex, urethra and fourchette as landmarks. Appropriate terminology should be used similar to cervical colposcopy (",
"    <a class=\"graphic graphic_table graphicRef86246 \" href=\"UTD.htm?29/5/29788\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/18/19747?source=see_link\">",
"     Ferric subsulfate",
"    </a>",
"    solution and pressure is usually all that are required for hemostasis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     VULVAR COLPOSCOPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vulvar colposcopy is indicated in women with:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Visible abnormalities of the vulva",
"     </li>",
"     <li>",
"      No abnormalities of the cervix or vagina that can account for the abnormal cervical cytology",
"     </li>",
"     <li>",
"      Focal vulvar itch, pain or burning, without a clear etiology.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Vulvar colposcopy is performed in a similar manner to cervical and vaginal colposcopy. Three to 5 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19011?source=see_link\">",
"     acetic acid",
"    </a>",
"    is applied to the external genitalia. It may take from three to five minutes for the solution to permeate the cells and for the lesion to appear white. Particular attention should be paid to peri-urethral and peri-anal areas. If clearly delineated lesions are noted, a vulvar biopsy is performed under local anesthesia using a 3 to 5 mm punch biopsy and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/53/42834?source=see_link\">",
"     silver nitrate",
"    </a>",
"    sticks for hemostasis. Alternately, a lesion may be excised with a scalpel and sutures placed. This may allow a lesion to be removed in entirety. Specimens are individually labeled according to their location on the vulva (eg, numbered and diagramed in the patient's record) and placed in separate specimen containers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     TRAINING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American College of Obstetricians and Gynecologists, the American Academy of Family Physicians, and the American Society for Colposcopy and Cervical Pathology (ASCCP) have developed curricula for the training of colposcopists. Estimates of the number of colposcopies that need to be performed to gain competence range from 25 to 100, including a minimum of 10 with high-grade lesions. As with any technical procedure, ongoing experience is necessary to maintain and enhance the operator's skills.",
"   </p>",
"   <p>",
"    A study of the colposcopy programs at 485 obstetrics and gynecology or family practice training programs in the United States reported that many graduates of these programs had not yet met the minimum number of procedures deemed necessary to have competence [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/24\">",
"     24",
"    </a>",
"    ]. Every effort should be made to concentrate these procedures among providers with the appropriate training and skills.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     ALTERNATIVES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colposcopy is the \"gold standard\" diagnostic tool in the United States for diagnosing cervical intraepithelial neoplasia following abnormal cytology [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/15\">",
"     15",
"    </a>",
"    ]; however, it is resource intensive and not cost-effective as a screening tool. The cervix can also be evaluated by other modalities. These may be divided into visualization techniques utilizing broad-band light (eg, direct visualization, speculoscopy, cervicography and colposcopy) and technologies utilizing electronic detection methods (eg, Polarprobe and in-vivo Spectroscopy). Four quadrant biopsy of the squamocolumnar junction is also an acceptable alternative where equipment and experienced personnel are not available [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/12,21\">",
"     12,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Visualization techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Visual inspection techniques have lower specificity than cytology and are generally used in low resource setting where cervical cytology and colposcopy are not feasible [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/25\">",
"     25",
"    </a>",
"    ]. Visual inspection of the cervix is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25156?source=see_link\">",
"     \"Cervical cancer screening tests: Visual inspection methods\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Electronic screening techniques",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Polarprobe and TruScan&trade;, Polartechnics Limited, Australia &mdash; This device utilizes the principle that both normal and abnormal cervical tissue have characteristic electrical and optical properties which can be measured using a combination of various light and electronic frequencies. The probe is placed onto the surface of the cervix and signals are transmitted between the cervix and the portable console. The emitted tissue \"signals\" are then compared algorithmically with known signals stored in a databank of cervical tissue types. Trials are currently underway analyzing its efficacy as a screening modality.",
"     </li>",
"     <li>",
"      Spectroscopy &mdash; Spectroscopy relies on the principle of differential light emission by various tissue types. The targeted tissues have an \"optical signature\" determined by the amount of light they absorb and emit. Biochemical and structural changes that underlie properties of various tissue types permit detection of the differences between normal and abnormal cervical tissues using a specialized fluorescent probe.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Electronic screening techniques are promising. In comparative trials of fluorescence spectroscopy versus colposcopy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/26\">",
"     26",
"    </a>",
"    ] and other diagnostic techniques, spectroscopy performed better. However, this technology is still under development and large-scale clinical trials will be required to determine true performance [",
"    <a class=\"abstract\" href=\"UTD.htm?24/14/24808/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Therefore, the current clinical role of these electronic devices is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/57/14227?source=see_link\">",
"       \"Patient information: Treatment of precancerous cells of the cervix (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2515?source=see_link\">",
"       \"Patient information: Management of atypical squamous cells (ASC-US and ASC-H) and low grade cervical squamous intraepithelial lesions (LSIL) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?16/44/17092?source=see_link\">",
"       \"Patient information: Management of high grade cervical squamous intraepithelial lesions (HSIL) and glandular abnormalities (AGC) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Colposcopy is a diagnostic procedure in which a colposcope is used to provide an illuminated, magnified view of the cervix, vagina, and vulva to look for malignant and premalignant epithelium. Malignant and premalignant epithelium have specific macroscopic characteristics relating to contour, color, and vascular pattern that can be identified by the colposcopist for directed biopsy. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Indications for colposcopy include further assessment of cervical cytological abnormalities, women exposed to DES in utero, women with HIV infection, women with gross abnormalities of the lower genital tract, and as an adjunct to surgery of the cervix, vagina, and vulva. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The cervix and vagina are examined with a bright light, and then with the colposcope, using saline if necessary. Pigmented areas and obvious lesions are noted. Three to 5 percent",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19011?source=see_link\">",
"       acetic acid",
"      </a>",
"      is applied to the cervix and the cervix is reexamined. A green-filter examination is subsequently performed to accentuate abnormal vasculature. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The colposcopic examination is considered adequate if the entire squamocolumnar junction is visible circumferentially around the os. In addition, the borders of all lesions should be completely visualized and biopsies of the lesions should explain the abnormal cytology. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Metaplastic cells, dysplastic cells, and cells infected with human papilloma virus reflect light and thus appear white. Areas of white epithelium are further evaluated for abnormal vascular patterns, such as punctation, mosaicism, or abnormal appearing vessels. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most abnormally appearing areas are biopsied. Biopsies are relatively contraindicated in patients on anticoagulation medication, who have a known bleeding disorder, or who are pregnant. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Biopsies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endocervical curettage or sampling is performed in patients with ASC-H, HSIL, AGC, adenocarcinoma in situ (AIS), LSIL but no visible lesion, if ablative treatment is contemplated, and those with an unsatisfactory colposcopic examination. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Endocervical curettage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Colposcopy by an experienced colposcopist will usually detect patients with significant disease (HSIL, cancer), but some women with a normal colposcopic examination can still have a significant histologic abnormality. For this reason, it is important to reconcile the cytologic, colposcopic, and histologic findings in formulating a diagnosis and management plan for each woman and following these women closely. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Effectiveness'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with persistent abnormalities of cervical cytology over time or who repeatedly test positive for high risk HPV, and whose initial colposcopy fails to reveal a significant lesion, should have multiple colposcopies and biopsies over time to rule out a high-grade lesion. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Effectiveness'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Follow-up'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/1\">",
"      Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007; 197:346.",
"     </a>",
"    </li>",
"    <li>",
"     www.ASCCP.org. (Accessed on August 13, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/3\">",
"      Chan YM, Lee PW, Ng TY, Ngan HY. Could precolposcopy information and counseling reduce women's anxiety and improve knowledge and compliance to follow-up? Gynecol Oncol 2004; 95:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/4\">",
"      Takacs P, Chakhtoura N, De Santis T. Video colposcopy improves adherence to follow-up compared to regular colposcopy: a randomized trial. Arch Gynecol Obstet 2004; 270:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/5\">",
"      Galaal KA, Deane K, Sangal S, Lopes AD. Interventions for reducing anxiety in women undergoing colposcopy. Cochrane Database Syst Rev 2007; :CD006013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/6\">",
"      MacLean AB. Acetowhite epithelium. Gynecol Oncol 2004; 95:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/7\">",
"      Ferris DG, Litaker MS, ALTS Group. Prediction of cervical histologic results using an abbreviated Reid Colposcopic Index during ALTS. Am J Obstet Gynecol 2006; 194:704.",
"     </a>",
"    </li>",
"    <li>",
"     file://screening.iarc.fr/viavilichap3.php?lang=1. (Accessed on August 13, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/9\">",
"      Castle PE, Wentzensen N, Wheeler CM, et al. Effect of the number of biopsies on the subsequent acquisition of new human papillomavirus infections. Obstet Gynecol 2009; 114:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/10\">",
"      Schmid BC, Pils S, Heinze G, et al. Forced coughing versus local anesthesia and pain associated with cervical biopsy: a randomized trial. Am J Obstet Gynecol 2008; 199:641.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/11\">",
"      Church L, Oliver L, Dobie S, et al. Analgesia for colposcopy: double-masked, randomized comparison of ibuprofen and benzocaine gel. Obstet Gynecol 2001; 97:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/12\">",
"      Pretorius RG, Zhang WH, Belinson JL, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004; 191:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/13\">",
"      Solomon D, Stoler M, Jeronimo J, et al. Diagnostic utility of endocervical curettage in women undergoing colposcopy for equivocal or low-grade cytologic abnormalities. Obstet Gynecol 2007; 110:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/14\">",
"      Bornstein J, Sideri M, Tatti S, et al. 2011 terminology of the vulva of the International Federation for Cervical Pathology and Colposcopy. J Low Genit Tract Dis 2012; 16:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/15\">",
"      American College of Obstetricians and Gynecologists. ACOG Practice Bulletin number 66, September 2005. Management of abnormal cervical cytology and histology. Obstet Gynecol 2005; 106:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/16\">",
"      Cantor SB, C&aacute;rdenas-Turanzas M, Cox DD, et al. Accuracy of colposcopy in the diagnostic setting compared with the screening setting. Obstet Gynecol 2008; 111:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/17\">",
"      Hopman EH, Voorhorst FJ, Kenemans P, et al. Observer agreement on interpreting colposcopic images of CIN. Gynecol Oncol 1995; 58:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/18\">",
"      Ferris DG, Litaker M, ALTS Group. Interobserver agreement for colposcopy quality control using digitized colposcopic images during the ALTS trial. J Low Genit Tract Dis 2005; 9:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/19\">",
"      Walker P, Dexeus S, De Palo G, et al. International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol 2003; 101:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/20\">",
"      Underwood M, Arbyn M, Parry-Smith W, et al. Accuracy of colposcopy-directed punch biopsies: a systematic review and meta-analysis. BJOG 2012; 119:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/21\">",
"      Guido RS, Jeronimo J, Schiffman M, et al. The distribution of neoplasia arising on the cervix: results from the ALTS trial. Am J Obstet Gynecol 2005; 193:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/22\">",
"      Gage JC, Hanson VW, Abbey K, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006; 108:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/23\">",
"      Jeronimo J, Schiffman M. Colposcopy at a crossroads. Am J Obstet Gynecol 2006; 195:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/24\">",
"      Spitzer M, Apgar BS, Brotzman GL, Krumholz BA. Residency training in colposcopy: a survey of program directors in obstetrics and gynecology and family practice. Am J Obstet Gynecol 2001; 185:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/25\">",
"      Wright TC Jr, Menton M, Myrtle JF, et al. Visualization techniques (colposcopy, direct visual inspection, and spectroscopic and other visual methods). Summary of task force 7. Acta Cytol 2002; 46:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/26\">",
"      Alvarez RD, Wright TC Jr, Optical Detection Group. Increased detection of high-grade cervical intraepithelial neoplasia utilizing an optical detection system as an adjunct to colposcopy. Gynecol Oncol 2007; 106:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/27\">",
"      Cardenas-Turanzas M, Freeberg JA, Benedet JL, et al. The clinical effectiveness of optical spectroscopy for the in vivo diagnosis of cervical intraepithelial neoplasia: where are we? Gynecol Oncol 2007; 107:S138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/14/24808/abstract/28\">",
"      Balasubramani L, Brown BH, Healey J, Tidy JA. The detection of cervical intraepithelial neoplasia by electrical impedance spectroscopy: the effects of acetic acid and tissue homogeneity. Gynecol Oncol 2009; 115:267.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3260 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-27EA24A548-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24808=[""].join("\n");
var outline_f24_14_24808=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CONTRAINDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      COLPOSCOPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Colposcope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Procedure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Repeat cervical cytology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Biopsies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Endocervical curettage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Documentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Follow-up",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      EFFECTIVENESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      VAGINAL COLPOSCOPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      VULVAR COLPOSCOPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      TRAINING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      ALTERNATIVES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Visualization techniques",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Electronic screening techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/3260\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3260|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/20/4423\" title=\"figure 1\">",
"      CIN terminology and histology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3260|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"UTD.htm?42/21/43345\" title=\"form 1\">",
"      Sample consent colposcopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"UTD.htm?12/63/13311\" title=\"form 2\">",
"      Colposcopy form BWH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3260|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/42/7854\" title=\"picture 1\">",
"      Colposcope on rolling stand",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/51/23344\" title=\"picture 2\">",
"      Squamocolumnar junction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/47/5872\" title=\"picture 3\">",
"      Low grade CIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/39/18032\" title=\"picture 4\">",
"      High grade CIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3260|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/52/41804\" title=\"table 1\">",
"      Colposcopy equipment supplies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/5/29788\" title=\"table 2\">",
"      Colposcopy terminology",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/4/64?source=related_link\">",
"      Acute cervicitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=related_link\">",
"      Approach to women with symptoms of vaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25156?source=related_link\">",
"      Cervical cancer screening tests: Visual inspection methods",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/15/40185?source=related_link\">",
"      Cervical cytology: Interpretation of results",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/2/30762?source=related_link\">",
"      Cervical intraepithelial neoplasia: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3322?source=related_link\">",
"      Outcome and follow-up of diethylstilbestrol (DES) exposed individuals",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2515?source=related_link\">",
"      Patient information: Management of atypical squamous cells (ASC-US and ASC-H) and low grade cervical squamous intraepithelial lesions (LSIL) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?16/44/17092?source=related_link\">",
"      Patient information: Management of high grade cervical squamous intraepithelial lesions (HSIL) and glandular abnormalities (AGC) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/57/14227?source=related_link\">",
"      Patient information: Treatment of precancerous cells of the cervix (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/16/38154?source=related_link\">",
"      Screening for cervical cancer: Rationale and recommendations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_14_24809="Basic case 14 with answer";
var content_f24_14_24809=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53626&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53626&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 482px\">",
"   <div class=\"ttl\">",
"    Typical left bundle branch block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 462px; height: 309px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram in typical complete LBBB. The asynchronous activation of the two ventricles increases the QRS duration (0.14 sec). The abnormal initial vector results in loss of normal septal forces as manifested by absence of physiologic q waves in leads I, aVL, and V6. The late activation of the left ventricle prolongs the dominant leftward progression of the middle and later depolarization forces, leading to a positive and widened R wave in the lateral leads. Both the ST segment and T wave vectors are opposite in direction from the QRS, a \"secondary\" repolarization abnormality.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24809=[""].join("\n");
var outline_f24_14_24809=null;
var title_f24_14_24810="Core uterine morcellation techn";
var content_f24_14_24810=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F56250&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F56250&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 601px\">",
"   <div class=\"ttl\">",
"    Uterine morcellation during vaginal hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 581px; height: 663px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A and B) Intramyometrial coring technique.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24810=[""].join("\n");
var outline_f24_14_24810=null;
var title_f24_14_24811="FDA classification";
var content_f24_14_24811=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F52143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F52143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    FDA classification of soft contact lenses",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Group 1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Low water content (&lt;50 percent)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Non-ionic polymer",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       HEMA hydrogels",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Silicone hydrogels",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Group 2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       High water content (&gt;50 percent)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Non-ionic polymer",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       HEMA hydrogels only",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Group 3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Low water content (&lt;50 percent)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Non-ionic polymer",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       HEMA hydrogels",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Silicone hydrogels",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Group 4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       High water content (&gt;50 percent)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Non-ionic polymer",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       HEMA hydrogels only",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: US Food and Drug Administration, www.fda.gov/cdrh/contactlenses/lenslist.html.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24811=[""].join("\n");
var outline_f24_14_24811=null;
var title_f24_14_24812="Treatment of hyperkalemia in children";
var content_f24_14_24812=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82874&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82874&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Treatment of hyperkalemia in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Agent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Onset of action",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Stabilization of cardiac myocardial membrane in setting of hyperkalemia-associated abnormal ECG or arrhythmia&Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Calcium gluconate, 10 percent*",
"       </td>",
"       <td>",
"        <p>",
"         0.5 to 1 mL/kg IV over 5 to 15 min (50 to&nbsp;100 mg/kg calcium gluconate, maxiumum dose 3 grams)",
"        </p>",
"        <p>",
"         Repeat after 10 minutes, if needed",
"        </p>",
"       </td>",
"       <td>",
"        Immediate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Movement of extracellular potassium into the cells&Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Glucose and insulin",
"       </td>",
"       <td>",
"        <p>",
"         IV administration of glucose 0.5 g/kg&nbsp;(equal to&nbsp;2 mL/kg of a 25 percent dextrose solution)&nbsp;",
"        </p>",
"        <p>",
"         IV administration of insulin 0.1 units/kg over 30 min",
"        </p>",
"       </td>",
"       <td>",
"        30 minutes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Inhaled beta-agonists (albuterol)",
"       </td>",
"       <td>",
"        0.1 to 0.3 mg/kg",
"       </td>",
"       <td>",
"        30 minutes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sodium bicarbonate&bull;",
"       </td>",
"       <td>",
"        IV administration of 1 mEq/kg over 10 min (maximum dose of 50 mEq per hour)",
"       </td>",
"       <td>",
"        15 minutes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Removal of potassium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sodium polystyrene sulfonate",
"       </td>",
"       <td>",
"        1 g/kg PO or PR with sorbitol",
"       </td>",
"       <td>",
"        1 to 2 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &nbsp;Furosemide",
"       </td>",
"       <td>",
"        IV administration of 1 to 2 mg/kg with replacement of fluid loss",
"       </td>",
"       <td>",
"        1 to 2 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &nbsp;Hemodialysis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IV: intravenous administration, PO: oral administration, PR: rectal administration, ECG: electrocardiogram.",
"     <br>",
"      <br>",
"       *Calcium should be administered in a larger vein or central line preferably (irritant), and sodium bicarbonate should not be introduced into the line because of potential precipitation. Continuous ECG monitoring should be performed during administration.",
"       <br>",
"        &bull;Administration of sodium bicarbonate may have a minimal effect.",
"        <br>",
"         &Delta;These measures do not remove potassium and additional interventions may be required to lower&nbsp;overall potassium levels.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24812=[""].join("\n");
var outline_f24_14_24812=null;
var title_f24_14_24813="Speech and language delay resources";
var content_f24_14_24813=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74444&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74444&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Resources related to speech and language delay/disorder for parents and clinicians",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Books for parents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Agin M, Geng L, and Nichol, M. The Late Talker: What To Do If Your Child Isn't Talking Yet, St. Martin's Press, New York 2003.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Feit D, with Feldman H. The Parent's Guide to Speech and Language Problems, McGraw-Hill, New York 2007.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Websites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Apraxia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Apraxia Kids",
"       </td>",
"       <td>",
"        <a href=\"file://www.apraxia-kids.org\" target=\"_blank\">",
"         www.apraxia-kids.org",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cherab: providing",
"        <strong>",
"         c",
"        </strong>",
"        ommunication",
"        <strong>",
"         h",
"        </strong>",
"        elp,",
"        <strong>",
"         e",
"        </strong>",
"        ducation,",
"        <strong>",
"         r",
"        </strong>",
"        esearch,",
"        <strong>",
"         a",
"        </strong>",
"        praxia-",
"        <strong>",
"         b",
"        </strong>",
"        ase",
"       </td>",
"       <td>",
"        <a href=\"file://www.cherab.org/information/speechlanguage/delayresources.html\" target=\"_blank\">",
"         www.cherab.org/information/speechlanguage/delayresources.html",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Autism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Autism Speaks",
"       </td>",
"       <td>",
"        <a href=\"file://www.autismspeaks.org\" target=\"_blank\">",
"         www.autismspeaks.org",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CDC's Learn the Signs/Act Early",
"       </td>",
"       <td>",
"        <a href=\"file://www.cdc.gov/ncbddd/actearly/index.html\" target=\"_blank\">",
"         www.cdc.gov/ncbddd/actearly/index.html",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Bilingual language development",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        American Speech-Language-Hearing Association",
"       </td>",
"       <td>",
"        <a href=\"file://www.asha.org/public/speech/development/bilingualchildren.htm\" target=\"_blank\">",
"         www.asha.org/public/speech/development/bilingualchildren.htm",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <a href=\"file://www.asha.org/public/speech/development/second.htm\" target=\"_blank\">",
"         www.asha.org/public/speech/development/second.htm",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Early language and literacy development",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Afasic England. Unlocking speech and language",
"       </td>",
"       <td>",
"        <a href=\"file://www.afasicengland.org.uk\" target=\"_blank\">",
"         www.afasicengland.org.uk",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        I Can",
"       </td>",
"       <td>",
"        <a href=\"file://www.ican.org.uk\" target=\"_blank\">",
"         www.ican.org.uk",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        National Center for Learning Disabilities: Get Ready to Read",
"       </td>",
"       <td>",
"        <a href=\"file://www.getreadytoread.org\" target=\"_blank\">",
"         www.getreadytoread.org",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Reach Out and Read",
"       </td>",
"       <td>",
"        <a href=\"file://www.reachoutandread.org\" target=\"_blank\">",
"         www.reachoutandread.org",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Reading Rockets",
"       </td>",
"       <td>",
"        <a href=\"file://www.readingrockets.org\" target=\"_blank\">",
"         www.readingrockets.org",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        General child development",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        American Academy of Pediatrics Bright Futures",
"       </td>",
"       <td>",
"        <a href=\"file://www.brightfutures.org\" target=\"_blank\">",
"         www.brightfutures.org",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        American Academy of Pediatrics Section on Developmental and Behavioral Pediatrics",
"       </td>",
"       <td>",
"        <a href=\"file://www.aap.org/sections/dbpeds\" target=\"_blank\">",
"         www.aap.org/sections/dbpeds",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Language disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        American Speech-Language-Hearing Association",
"       </td>",
"       <td>",
"        <a href=\"file://www.asha.org/public/speech/disorders/ChildSandL.htm\" target=\"_blank\">",
"         www.asha.org/public/speech/disorders/ChildSandL.htm",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Stuttering",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        National Stuttering Association",
"       </td>",
"       <td>",
"        <a href=\"file://www.nsastutter.org\" target=\"_blank\">",
"         www.nsastutter.org",
"        </a>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The Stuttering Foundation",
"       </td>",
"       <td>",
"        <a href=\"file://www.stutteringhelp.org\" target=\"_blank\">",
"         www.stutteringhelp.org",
"        </a>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24813=[""].join("\n");
var outline_f24_14_24813=null;
var title_f24_14_24814="Percentage of donor oocyte";
var content_f24_14_24814=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F53489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F53489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 530px\">",
"   <div class=\"ttl\">",
"    Percentage of ART cycles using donor eggs, by age of woman, 2007",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 510px; height: 394px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. 2007 ART Report Section 4-ART Cycles Using Donor Eggs.",
"     <a href=\"file://www.cdc.gov/art/ART2007/section4.htm\">",
"      file://www.cdc.gov/art/ART2007/section4.htm",
"     </a>",
"     accessed November 22, 2010.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24814=[""].join("\n");
var outline_f24_14_24814=null;
var title_f24_14_24815="Hymenoptera taxonomy";
var content_f24_14_24815=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F80397&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F80397&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 629px\">",
"   <div class=\"ttl\">",
"    Overview of taxonomy of common Hymenoptera (stinging insects)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 609px; height: 383px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_14_24815=[""].join("\n");
var outline_f24_14_24815=null;
